UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
   
þ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended: August 31, 2005February 28, 2006
or
   
o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from                                        to                                        
Commission File Number 1-15201-01520
GenCorp Inc.
(Exact name of registrant as specified in its charter)
   
Ohio34-0244000

(State of Incorporation)
 34-0244000
(I.R.S. Employer Identification No.)
   
Highway 50 and Aerojet Road95742

Rancho Cordova, California
(Zip Code)

(Address of Principal Executive Offices)
 95742
(Zip Code)
   
P.O. Box 53701295853-7012

Sacramento, California
(Zip Code)

(Mailing Address)
 95853-7012
(Zip Code)
Registrant’s telephone number, including area code (916) 355-4000
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YesRþ No£
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, (as definedor a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Act). YesExchange Act. (Check one): Large accelerated filerRþ NoAccelerated filer£o Non-accelerated filero
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.)¨Exchange Act). YesRo Noþ
     As of September 30, 2005,March 31, 2006, there were 54,855,47455.3 million outstanding shares of our Common Stock, $0.10 par value.
 
 

 


GenCorp Inc.
Quarterly Report on Form 10-Q
For the Quarterly Period Ended August 31,February 28, 2005
Table of Contents
     
Item   
Number Page 
  3 
  30 
  39 
  4039 
  4140 
  41 
  4241 
  4241 
  4241 
  41
SIGNATURES
Signatures42 
Exhibit Index  43 
EXHIBIT INDEX
44
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1

2


Part I FINANCIAL INFORMATION
Item 1. Financial Statements
GenCorp Inc.
Condensed Consolidated Statements of IncomeOperations
(Unaudited)
        
                 Three months ended 
 Three months ended August 31, Nine months ended August 31,  February 28, February 28, 
 2005 2004 2005 2004  2006 2005 
 (in millions, except per share amounts)  (In millions, except per share amounts) 
Net Sales
 $134 $116 $421 $350  $128.7 $139.9 
Costs and Expenses
  
Cost of products sold 120 114 381 319  121.8 130.3 
Selling, general and administrative 6 11 22 34  8.0 7.5 
Depreciation and amortization 7 8 21 25  6.5 6.7 
Other (income) expense, net  (0.1) 0.2 
Interest expense 6 9 19 25  6.3 7.1 
Unusual items   20    18.1 
Other income, net   (14)   (14)
              
Loss from continuing operations before income taxes  (5)  (12)  (42)  (39)
Income tax benefit (provision)   (3) 13  (33)
Loss from continuing operations before income taxes and cumulative effect of a change in accounting principle  (13.8)  (30.0)
Income tax provision 0.6  
              
Loss from continuing operations  (5)  (15)  (29)  (72)
Loss from discontinued operations, net of tax  (24)  (32)  (25)  (306)
Loss from continuing operations before cumulative effect of a change in accounting principle  (14.4)  (30.0)
Loss from discontinued operations, net of income taxes  (0.9)  (1.4)
     
Loss before the cumulative effect of a change in accounting principle  (15.3)  (31.4)
Cumulative effect of a change in accounting principle, net of income taxes  (0.7)  
              
Net loss $(29) $(47) $(54) $(378) $(16.0) $(31.4)
              
Loss Per Share of Common Stock
  
Basic and Diluted:  
Loss per share from continuing operations $(0.08) $(0.33) $(0.53) $(1.63)
Loss per share from continuing operations before cumulative effect of a change in accounting principle $(0.26) $(0.55)
Loss per share from discontinued operations  (0.45)  (0.72)  (0.47)  (6.91)  (0.02)  (0.03)
Loss per share from cumulative effect of a change in accounting principle  (0.01)  
              
Loss per share $(0.53) $(1.05) $(1.00) $(8.54)
Net loss per share $(0.29) $(0.58)
              
Weighted average shares of common stock outstanding 54.7 44.5 54.5 44.2  55.1 54.2 
              
Dividends Declared Per Share of Common Stock
 $ $ $ $0.06 
         
See Notes to Unaudited Condensed Consolidated Financial Statements.

3


GenCorp Inc.
Condensed Consolidated Balance Sheets
        
         February 28, November 30, 
 August 31, November 30,  2006 2005 
 2005 2004  (Unaudited) 
 (Unaudited)  (In millions, except 
 (in millions, except per share amounts)  per share amounts) 
ASSETS
  
Current Assets
  
Cash and cash equivalents $3 $68  $50.4 $91.7 
Restricted cash  23 
Accounts receivable, net 96 88 
Inventories, net 194 159 
Accounts receivable 73.8 82.1 
Inventories 73.2 57.5 
Recoverable from the U.S. government and other third parties for environmental remediation costs 47 36  31.9 24.6 
Prepaid expenses and other 11 6  23.5 24.7 
Assets of discontinued operations 110 94 
          
Total Current Assets 461 474  252.8 280.6 
Noncurrent Assets
  
Restricted cash  178 
Property, plant and equipment, net 137 145  137.3 140.2 
Recoverable from the U.S. government and other third parties for environmental remediation costs 171 197  162.6 171.4 
Prepaid pension asset 245 278  222.5 233.2 
Goodwill 103 103  102.0 102.0 
Intangible assets, net 27 28 
Intangible assets 27.1 27.5 
Other noncurrent assets, net 98 92  98.2 102.5 
          
Total Noncurrent Assets 781 1,021  749.7 776.8 
          
Total Assets $1,242 $1,495  $1,002.5 $1,057.4 
          
LIABILITIES AND SHAREHOLDERS’ EQUITY
 
LIABILITIES AND SHAREHOLDERS’ DEFICIT
 
Current Liabilities
  
Short-term borrowings and current portion of long-term debt $2 $23  $1.1 $1.4 
Accounts payable 35 55  30.4 57.1 
Reserves for environmental remediation 64 51  58.8 51.7 
Income taxes payable 23 35  6.4 5.9 
Postretirement benefits other than pensions 14 15 
Postretirement medical and life benefits 11.8 11.9 
Other current liabilities 134 141  145.1 142.5 
Liabilities of discontinued operations 26 18  1.8 1.9 
          
Total Current Liabilities 298 338  255.4 272.4 
Noncurrent Liabilities
  
Convertible subordinated notes 291 285  291.2 291.2 
Senior subordinated notes 98 150  97.5 97.5 
Other long-term debt, net of current portion 33 119  53.5 53.8 
Reserves for environmental remediation 220 253  203.0 216.3 
Postretirement benefits other than pensions 139 149 
Postretirement medical and life benefits 132.9 137.9 
Other noncurrent liabilities 61 60  52.6 61.0 
          
Total Noncurrent Liabilities 842 1,016  830.7 857.7 
          
Total Liabilities 1,140 1,354  1,086.1 1,130.1 
     
Commitments and Contingent Liabilities
 
Shareholders’ Equity
 
Commitments and Contingencies (Note 10) 
Shareholders’ Deficit 
Preference stock, par value of $1.00; 15 million shares authorized; none issued or outstanding      
Common stock, par value of $0.10; 150 million shares authorized; 55.4 million shares issued, 54.8 million outstanding as of August 31, 2005; 54.6 million shares issued, 54.0 million shares outstanding as of November 30, 2004 5 5 
Common stock, par value of $0.10; 150 million shares authorized; 55.9 million shares issued, 55.3 million outstanding as of February 28, 2006; 55.6 million shares issued, 55.0 million shares outstanding as of November 30, 2005 5.5 5.5 
Other capital 180 167  186.4 181.3 
Accumulated deficit  (82)  (28)  (273.9)  (257.9)
Accumulated other comprehensive loss, net of income taxes  (1)  (3)  (1.6)  (1.6)
          
Total Shareholders’ Equity 102 141 
Total Shareholders’ Deficit  (83.6)  (72.7)
          
Total Liabilities and Shareholders’ Equity $1,242 $1,495 
Total Liabilities and Shareholders’ Deficit $1,002.5 $1,057.4 
          
See Notes to Unaudited Condensed Consolidated Financial Statements.

4


GenCorp Inc.
Condensed Consolidated Statement of Shareholders’ Deficit
(Unaudited)
                         
                  Accumulated    
                  Other  Total 
  Common Stock  Other  Accumulated  Comprehensive  Shareholders’ 
  Shares  Amount  Capital  Deficit  Loss  Deficit 
  (In millions, except share and per share amounts)
November 30, 2005
  54,962,624  $5.5  $181.3  $(257.9) $(1.6) $(72.7)
Net loss           (16.0)     (16.0)
Shares issued under stock option and stock incentive plans, net of income tax  310,330      5.1         5.1 
                   
February 28, 2006
  55,272,954  $5.5  $186.4  $(273.9) $(1.6) $(83.6)
                   

5


GenCorp Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
        
         Three months ended 
 Nine months ended  February 28, February 28, 
 August 31, August 31,  2006 2005 
 2005 2004  (in millions) 
 (in millions)  (Revised) 
Operating Activities
  
Loss from continuing operations $(29) $(72)
Adjustments to reconcile loss to net cash used in continuing operations: 
Net loss $(16.0) $(31.4)
Loss from discontinued operations, net of income taxes 0.9 1.4 
Cumulative effect of a change in accounting principle, net of income taxes 0.7  
Adjustments to reconcile net loss to net cash used in operating activities: 
Depreciation and amortization 21 25  6.5 6.7 
Deferred income taxes  28 
Stock compensation and savings plan expense 9 6  2.8 2.0 
Loss on repayment of debt 18    18.1 
Changes in assets and liabilities:  
Current assets  (60)  (17)  (13.3)  (28.2)
Noncurrent assets 55 15  23.5 14.5 
Current liabilities  (26)  (33)  (11.8)  (19.2)
Noncurrent liabilities  (47) 4   (26.6)  (16.0)
          
Net cash used in continuing operations  (59)  (44)  (33.3)  (52.1)
Net cash used in discontinued operations  (6)  (32)  (7.2)  (0.9)
          
Net Cash Used in Operating Activities  (65)  (76)  (40.5)  (53.0)
Investing Activities
  
Capital expenditures  (9)  (11)  (2.5)  (1.7)
Proceeds from business disposition  140 
Restricted cash 201  (70)  201.3 
Investing activities of discontinued operations  (28)  (37)   (7.1)
          
Net Cash Provided by Investing Activities 164 22 
Net Cash (Used in) Provided by Investing Activities  (2.5) 192.5 
Financing Activities
  
Proceeds from issuance of convertible notes 66 125   66.4 
Repayment of convertible and senior subordinated notes  (122)     (121.6)
Borrowings (repayments) on revolving credit facility 10  (30)
Repayments of short-term debt   (28)  (0.3)  
Proceeds from the issuance of other long-term debt 25 2   25.0 
Repayments of other long-term debt  (141)  (39)  (0.3)  (141.6)
Debt issuance costs  (6)  (5)  (0.6)  (6.0)
Dividends paid   (2)
Tax benefit on stock options 0.3  
Other equity transactions 4 2  2.6 1.7 
          
Net Cash (Used In) Provided by Financing Activities  (164) 25 
     
Effect of exchange rate fluctuations on cash and cash equivalents   (4)
Net Cash Provided by (Used in) Financing Activities 1.7  (176.1)
          
Net Decrease in Cash and Cash Equivalents
  (65)  (33)  (41.3)  (36.6)
Cash and Cash Equivalents at Beginning of Period 68 64  91.7 67.9 
          
Cash and Cash Equivalents at End of Period $3 $31  $50.4 $31.3 
          
See Notes to Unaudited Condensed Consolidated Financial Statements.

56


GenCorp Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
1. Basis of Presentation and Nature of Operations
     GenCorp Inc. (GenCorp or the Company) has prepared the accompanying Unaudited Condensed Consolidated Financial Statements, including its accounts and the accounts of its wholly owned and majority-owned subsidiaries, in accordance with the instructions to Form 10-Q and therefore do not include all of the information and notes required by accounting principles generally accepted in the United States of America (GAAP). These interim financial statements should be read in conjunction with the financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended November 30, 2004,2005, as filed with the Securities and Exchange Commission (SEC).
     The Company believes the accompanying Unaudited Condensed Consolidated Financial Statements reflect all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation of its financial position, results of operations and cash flows for the periods presented. All significant intercompany balances and transactions have been eliminated in consolidation. The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In addition, the operating results for interim periods may not be indicative of the results of operations for a full year.
     The Company revised its Condensed Consolidated Statement of Cash Flows for the first quarter of fiscal 2005 to reconcile the net loss to net cash used in operating activities. Previously, the Company reconciled loss from continuing operations to net cash used in operating activities.
     The Company is a technology-based manufacturer operating primarily inof aerospace and defense products and systems with a real estate business segment that includes activities related to the United States.entitlement, sale, and leasing of the Company’s excess real estate assets. The Company’s continuing operations are organized into two operating segments:
Aerospace and Defense and Real Estate. The Aerospace and Defense segment includes the operations of Aerojet-General Corporation, (Aerojet),or Aerojet, which develops and manufactures propulsion systems for spacedefense and defensespace applications, armament systems for precision tactical weapon systems and munitions applications,applications. The Company is one of the largest providers of propulsion systems in the United States and advanced airframe structures.the only company that provides both Solid and Liquid propellant based systems. Primary customers served include major prime contractors to the U.S.United States (U.S.) government, the Department of Defense (DoD), and the National Aeronautics and Space Administration (NASA). The
Real Estate segment includes activities related to the development,re-zoning, entitlement, sale, and leasing of the Company’sour real estate assets. The Company owns approximately 12,600 acres of land adjacent to U.S. Highway 50 between Rancho Cordova and Folsom, California just east of Sacramento (Sacramento Land). The Company is currently in the process of seeking zoning changes and other governmental approvals on a portion of the Sacramento Land to optimize its value. The Company has filed applications with and submitted information to governmental and regulatory authorities for approvals necessary to re-zone over 6,400 acres of the Sacramento Land.
     On August 31, 2004,November 30, 2005, the Company completed the sale of its GDX Automotive (GDX) business. In July 2005, the Company announced its plan to sell the Fine Chemicals business, to American Pacific Corporation for $119 million, consisting of $100 million of cash, seller note of $19 million, and the assumption by the buyer of certain liabilities. American Pacific Corporation and the Company recently agreed to amend the purchase agreement to modify the sale price and payment terms related to the Fine Chemicals sale. The revised purchase price consists of $89 million of cash payable at closing, seller note of $25 million delivered at closing, a contingent payment of up to $5 million if Fine Chemicals achieves specified earning targets in the twelve month period ending September 30, 2006, and the assumption by the buyer of certain liabilities. The Company has recorded a loss of $28 million in the third quarter based on the difference between current estimated cash proceeds to be received on disposition less the carrying value of net assets being sold and related transaction selling costs. Income will be recorded in the future on the seller note of $25 million and any contingent payment when realized. The Company continues to expect the transaction to close in October 2005. The GDX and Fine Chemicals businesses arewhich is classified as discontinued operations in these Unaudited Condensed Consolidated Financial Statements and Notes to Unaudited Condensed Consolidated Financial Statements (see Note 13)14). In addition, the assets and liabilities remaining related to the GDX operations after the sale to Cerberus Capital Management, L.P. on August 31, 2004 are classified as discontinued operations in these Unaudited Condensed Consolidated Financial Statements and Notes to Unaudited Condensed Consolidated Financial Statements.
     A detailed description of the Company’s significant accounting policies can be found in the Company’s most recent Annual Report on Form 10-K for the fiscal year ended November 30, 2005.
     As of December 1, 2005, the Company adopted Statement of Financial Accounting Standards (SFAS) No. 123(R),Share-Based Payment,(SFAS 123(R)), which requires companies to recognize in the statement of operations the grant-date fair value of stock awards issued to employees and directors. The Company adopted SFAS 123(R) using the modified prospective transition method. In accordance with the modified prospective transition method, the Company’s Consolidated Financial Statements for prior periods have not been restated to reflect the impact of SFAS 123(R). As a result of applying SFAS 123(R), the loss from continuing operations

67


before the cumulative effect of a change in accounting principle for the first quarter of fiscal 2006 was increased by $0.4 million. In addition, the Company recognized an increase to its net loss of $0.7 million related to the cumulative effect of a change in accounting principle as of December 1, 2005 (see Note 3).
     In March 2005, the FASB issued Interpretation No. 47(FIN 47),Accounting for Conditional Asset Retirement Obligations, an interpretation of FASB Statement No. 143,Accounting for Asset Retirement Obligations. FIN 47 requires an entity to recognize a liability for the fair value of a conditional asset retirement obligation when incurred if the liability’s fair value can be reasonably estimated. This interpretation is effective for fiscal years ending after December 15, 2005. The Company is currently evaluating the effect that the adoption of FIN 47 will have on its financial position and results of operations which the Company will adopt in the fourth quarter of fiscal 2006.
2. Loss Per Share of Common Stock
     A reconciliation of the numerator and denominator used to calculate basic and diluted loss per share of common stock (EPS) is presented in the following table:
        
 Three months ended 
                 February 28, February 28, 
 Three months ended August 31, Nine months ended August 31,  2006 2005 
 2005 2004 2005 2004  (in millions, except per share 
 (in millions, except per share amounts; shares in thousands)  amounts; shares in thousands) 
Numerator for Basic and Diluted EPS:  
Loss from continuing operations $(5) $(15) $(29) $(72)
Loss from discontinued operations, net of tax  (24)  (32)  (25)  (306)
Loss from continuing operations before the cumulative effect of a change in accounting principle $(14.4) $(30.0)
Loss from discontinued operations, net of income taxes  (0.9)  (1.4)
Cumulative effect of a change in accounting principle, net of income taxes  (0.7)  
              
Net loss available to common shareholders $(29) $(47) $(54) $(378) $(16.0) $(31.4)
              
Denominator for Basic and Diluted EPS:  
Weighted average shares of common stock outstanding 54,738 44,516 54,474 44,208  55,086 54,180 
              
Basic and Diluted:  
Loss per basic share from continuing operations $(0.08) $(0.33) $(0.53) $(1.63)
Loss per basic share from discontinued operations  (0.45)  (0.72)  (0.47)  (6.91)
Loss per share from continuing operations before the cumulative effect of a change in accounting principle $(0.26) $(0.55)
Loss per share from discontinued operations  (0.02)  (0.03)
Loss per share from cumulative effect of a change in accounting principle  (0.01)  
              
Net loss per share $(0.53) $(1.05) $(1.00) $(8.54) $(0.29) $(0.58)
              
     The following were not included in the computation of diluted loss per share for the threefirst quarter of fiscal 2006 and nine months ended August 31,fiscal 2005 because the effect would be antidilutive for the periods:
   
Description Conversion Rate
5 ¾%3/4% Convertible Subordinated Notes
54.29 shares per $1,000 outstanding
4% Contingent Convertible Subordinated Notes (4% Notes)64.81 Shares per $1,000 outstanding
2 ¼% Convertible Subordinated Debentures50.00 Shares per $1,000 outstanding
     The following were not included in the computation of diluted loss per share for the three and nine months ended August 31, 2004 because the effect would be antidilutive for the periods:
DescriptionConversion Rate
5 ¾% Convertible Subordinated Notes 54.29 shares per $1,000 outstanding
4% Contingent Convertible Subordinated Notes 64.81 Shares per $1,000 outstanding
21/4% Convertible Subordinated Debentures
50.00 Shares per $1,000 outstanding
     The holders of the 4% Notes had the right to convert their notes into GenCorp’s common stock during the calendar quarter ending September 30, 2005 (for the period July 1, 2005 through September 30, 2005) because the stock price contingent conversion condition was met in the calendar quarter ended June 30, 2005. As discussed above, the shares relating to the 4% Notes were not included in the computation of diluted loss per share because the effect would be antidilutive for the three and nine months ended August 31, 2005 and 2004. The holders of the 4% Notes will also be able to convert their notes into GenCorp’s common stock for the period October 1, 2005 through December 31, 2005 because the stock price contingent was met in the calendar quarter ended September 30, 2005.
     Potentially dilutive securities that are not included in the diluted EPS calculation, for the nine months ended August 31, 2005 and the three and nine months ended August 31, 2004, because they would be antidilutive, also include 2.01.7 million and 3.02.2 million employee stock options as of August 31,February 28, 2006 and 2005, and August 31, 2004, respectively.
3. Stock Based Compensation
     The Financial Accounting Standards Board (FASB) issued Statement No. 123(R),Share-Based Payment,inOn December 2004. Statement No. 123(R) which will require1, 2005, the Company adopted SFAS 123(R), which requires the measurement and recognition of compensation expense for all stock-based payment awards made to measure allemployees and directors, including employee stock-based compensation awardsstock options, restricted stock, and stock appreciation rights (SARS) based on estimated fair values. The Company adopted SFAS 123(R) using a fair valuethe modified prospective transition method, and record such expense inwhich requires application of the Company’s consolidated financial statements. In Aprilaccounting standard as of December 1, 2005, the Securities and Exchange Commission issued a release which amends the compliance dates for Statement 123(R). The Company will now be required to adopt the new accounting provisions beginning in the first quarterday of fiscal year 2006. UntilThe Unaudited Condensed Consolidated Financial Statements as of and for the Company adoptsthree months ended February 28, 2006 reflect the impact of SFAS No. 123(R) in. In accordance with the modified prospective transition method, the Consolidated Financial Statements for prior periods have not been restated to reflect the impact of SFAS 123(R). Therefore, the results for the first quarter of fiscal 2006 are not directly comparable to the Company will continuesame period in the prior year.

8


Prior to account for its stock compensation in accordance with Accounting Principles Board (APB) No. 25,Accounting for Stock Issued to Employeesthe adoption of SFAS 123(R).
     AsPrior to the adoption of SFAS 123(R), as permitted by Statement of Financial Accounting Standards (SFAS)SFAS No. 123,Accounting for Stock-Based Compensation, (SFAS 123) and SFAS No. 148,Accounting for Stock-Based Compensation Transition and Disclosure, the Company appliesapplied the existing accounting

7


rules under APB Opinion No. 25,Accounting for Stock Issued to Employees, (APB 25) which providesprovided that no compensation expense iswas charged for options granted at an exercise price equal to the market value of the underlying common stock on the date of grant. HadIn addition, the Company did not record any significant stock-based compensation expense forrelated to SARS under the stock option plans been determined based upon the fairintrinsic value at the grant date for awards under these plans using market-based option valuation models, the net loss andmethod in accordance with SFAS 123.
     The following table illustrates the effect on net loss and net loss per share would have beenas if the Company had applied the fair value recognition provisions of SFAS 123 to awards granted under the Company’s stock-based compensation plans prior to the adoption. For purposes of this pro forma disclosure, the value of the options was estimated using a Black-Scholes option-pricing model (Black-Scholes Model) and amortized on a straight-line basis over the respective vesting periods of the awards. The disclosure for the first quarter of fiscal 2006 was not presented because stock-based awards were accounted for under SFAS 123(R)’s fair-value method during this period.
     
  Three months 
  ended 
  February 28, 
  2005 
  (in millions, except 
  per share amounts) 
Net loss, as reported $(31.4)
Add: Stock based compensation expense reported, net of related tax effects  0.3 
Deduct: Stock based compensation expense determined under fair value based method for all awards, net of related tax effects  (0.4)
    
Net loss, pro forma $(31.5)
    
As reported    
Basic and diluted $(0.58)
    
Pro forma    
Basic and diluted $(0.58)
    
Adoption of SFAS 123(R)
     The following table details the impact of adopting SFAS 123(R) during the most recent quarter:
     
  Three months 
  ended 
  February 28, 
  2006 
  (in millions, except 
  per share amounts) 
Effect on loss from continuing operations $(0.4)
Cumulative effect of change in accounting principle, net of income taxes  (0.7)
    
Net loss $(1.1)
    
     
Effect on basic and diluted net loss per share $(0.02)
    

9


     Total stock-based compensation expense by type of award for the first quarter of fiscal 2006 was as follows:
                 
  Three months ended August 31,  Nine months ended August 31, 
  2005  2004  2005  2004 
  (in millions, except per share amounts) 
Net loss, as reported $(29) $(47) $(54) $(378)
Add: Stock based compensation expense reported, net of related tax effects  1      3    
Deduct: Stock based compensation expense determined under fair value based method for all awards, net of related tax effects  (1)     (3)   
             
Net loss, pro forma $(29) $(47) $(54) $(378)
             
As reported loss per share of common stock                
Basic and diluted $(0.53) $(1.05) $(1.00) $(8.54)
             
Pro forma loss per share of common stock                
Basic and diluted $(0.53) $(1.05) $(1.00) $(8.54)
             
     
  Three months 
  ended 
  February 28, 
  2006 
  (in millions, except 
  per share amounts) 
Stock appreciation rights $1.0 
Restricted stock, service based  0.1 
Restricted stock, performance based  0.1 
Stock options  0.1 
    
Total stock-based compensation expense $1.3 
Tax effect on stock based compensation expense   
    
Net effect on stock-based compensation expense $1.3 
    
     
Effect on basic and diluted net loss per share $(0.02)
    
     As of February 28, 2006, the Company had 150.0 million authorized shares of common stock, par value $0.10 per share, of which 55.9 million shares were issued, 55.3 million shares were outstanding and 22.0 million shares were reserved for future issuance for discretionary payments of the Company’s portion of retirement savings plan contributions, exercise of stock options (ten year contractual life) and restricted stock (no maximum contractual life), payment of awards under stock-based compensation plans, and conversion of the Company’s Notes.
Stock Appreciation Rights.Asof February 28, 2006, a total of 517,643 SARS were outstanding under the 1999 Equity and Performance Incentive Plan (1999 Plan). The SARS granted to key employees in general, exercisable in one-third increments at one year, two years, and three years from the date of grant and have a ten year contractual life. The SARS granted to directors of the Company primarily vest over a one year service period and have a ten year contractual life. These awards are similar to the Company’s employee stock options, but are settled in cash rather than in shares of common stock and are classified as liability awards. Under APB 25, compensation cost for these awards was recognized at the intrinsic value. The Company did not incur any significant compensation charges related to the SARS during fiscal 2005. Under the provisions of SFAS 123 (R), compensation cost for these awards is determined using a fair-value method and remeasured at each reporting date until the date of settlement. Stock-based compensation expense recognized for the first quarter of fiscal 2006 is based on SARS ultimately expected to vest, and therefore it has been reduced for estimated forfeitures.
     As of February 28, 2006, there was $3.5 million of total stock-based compensation related to nonvested SARS. That cost is expected to be recognized over an estimated weighted-average amortization period of 29 months. The intrinsic value of the SARS exercisable and outstanding at February 28, 2006 was less than $0.1 million. The weighted average grant date fair value for SARS granted in the first quarter of fiscal 2005 was $10.28.
     A summary of the Company’s SARS activity and related information for the first quarter of fiscal 2006 is as follows:
         
      Weighted 
      Average 
  SARS  Grant Date 
  (000s)  Fair Value 
Outstanding at November 30, 2005  269  $8.81 
Granted  251  $11.34 
Forfeited/canceled  (2) $7.67 
        
Outstanding at February 28, 2006  518  $10.26 
        
Exercisable at November 30, 2005  9  $11.89 
Vested  49  $9.88 
        
Exercisable at February 28, 2006  58  $10.28 
        
Restricted Stock, service based:As of February 28, 2006, a total of 155,250 shares of service based restricted stock was outstanding which vest based on years of service under the 1999 Plan. Restricted shares are granted to key employees and directors of the Company. During the first quarter of fiscal 2006, the Company’s Organization & Compensation Committee of the Board approved

10


the grant of 30,000 restricted shares to the Company’s key employees. The fair value of the restricted stock awards was based on the closing market price of the Company’s common stock on the date of award and is being amortized straight line over the service period. Stock-based compensation expense recognized for the first quarter of fiscal 2006 is based on service based restricted stock ultimately expected to vest, and therefore it has been reduced for estimated forfeitures.
     As of February 28, 2006, there was $1.2 million of total stock-based compensation related to nonvested service based restricted stock. That cost is expected to be recognized over an estimated weighted-average amortization period of 31 months. The intrinsic value of the service based restricted stock outstanding at February 28, 2006 was $3.0 million. Additionally, the intrinsic value of the service based restricted stock vested during the first quarter of fiscal 2006 and fiscal 2005 was $0.1 million. The weighted average grant date fair value for restricted stock granted in the first quarter of fiscal 2005 was $18.59.
     A summary of the Company’s service based restricted stock activity, and related information for the first quarter of fiscal 2006 is as follows:
         
  Service    
  Based  Weighted 
  Restricted  Average 
  Stock  Grant Date 
  (000s)  Fair Value 
Outstanding at November 30, 2005  139  $14.73 
Granted  30  $19.40 
Exercised/vested  (6) $7.73 
Forfeited/canceled  (8) $10.27 
        
Outstanding at February 28, 2006  155  $16.25 
        
Restricted Stock, performance based:As of February 28, 2006, a total of 197,245 shares of performance based restricted shares were outstanding under the 1999 Plan. The restricted stock primarily vests if the Company meets various operations and earnings targets set by the Organization & Compensation Committee of the Board. During the first quarter of fiscal 2006, the Company’s Organization & Compensation Committee of the Board approved the grant of 103,750 restricted shares to the Company’s key employees. The fair value of the restricted stock awards was based on the closing market price of the Company’s common stock on the date of award and is being amortized over the estimated service period to achieve the operations and earnings targets. Stock-based compensation expense recognized for the first quarter of fiscal 2006 is based on performance based restricted stock ultimately expected to vest, and therefore it has been reduced for estimated forfeitures.
     As of February 28, 2006, there was $3.2 million of total stock-based compensation related to nonvested performance based restricted stock. The underlying performance criteria set by the Organization & Compensation Committee of the Board relate to meeting certain annual earnings and cash flow targets and achieving certain real estate related milestones within specific time frames through the year 2009. Based on the Company’s current projections, approximately $0.9 million of the $3.2 million is not currently expected to vest. The $2.3 million of nonvested performance based stock cost will be recognized over an estimated amortization period of when the performance targets are expected to be met. The intrinsic value of the performance based restricted stock outstanding at February 28, 2006 was $3.8 million. The weighted average grant date fair value for restricted stock granted in the first quarter of fiscal 2005 was $18.61.
     A summary of the Company’s performance based restricted stock activity, and related information for the first quarter of fiscal 2006 is as follows:
         
  Performance    
  Based  Weighted 
  Restricted  Average 
  Stock  Grant Date 
  (000s)  Fair Value 
Outstanding at November 30, 2005  204  $15.65 
Granted  104  $18.61 
Exercised/vested       
Forfeited/canceled  (111) $10.96 
        
Outstanding at February 28, 2006  197  $19.05 
        
Stock Options:As of February 28, 2006, a total of 1,726,331 stock options were outstanding under the 1999 Plan and the 1997 Stock Option Plan. The Company has not granted stock options to employees or directors since February 2004. Stock-based

11


compensation expense recognized for the first quarter of fiscal 2006 included compensation expense for stock options granted prior to, but not yet vested as of December 1, 2005, based on the grant date fair value estimated in accordance with the pro forma provisions of SFAS 123. Included in stock-based compensation expense in the first quarter of fiscal 2006 was $0.1 million related to stock options which is net of the estimated forfeitures. The intrinsic value of the stock options exercised during the first quarter of fiscal 2005 was $1.0 million. The fair value of the stock options which vested during the first quarter of fiscal 2006 and fiscal 2005 was $0.8 million and $0.9 million, respectively.
     As of February 28, 2006, there was $0.1 million of total stock-based compensation related to nonvested stock options. That cost is expected to be recognized over an estimated amortization period of 1 year.
     A summary of the Company’s stock option activity and related information for the first quarter of fiscal 2006 is as follows:
                 
          Weighted    
      Weighted  Average  Aggregate 
  Stock  Average  Remaining  Intrinsic 
  Options  Exercise  Contractual  Value 
  (000s)  Price  Life  (in millions) 
Outstanding at November 30, 2005  1,915  $11.15         
Exercised  (187) $13.45      $1.1 
Forfeited/canceled  (2) $10.63         
                
Outstanding at February 28, 2006  1,726  $10.89   4.66  $14.4 
                
Exercisable at February 28, 2006  1,697  $10.93   4.61  $14.1 
                
Valuation Assumptions
     The fair value of optionsSARS granted was estimated at the measurement date of grantFebruary 28, 2006 using a Black-Scholes stock option pricing modelModel with the following weighted average assumptions:
     
  NineThree months ended
  August 31, 2004ended
 February 28,
2006
Expected life (in years)  5.007.5 
Volatility  42.0042.66%
Risk-free interest rate  3.074.66%
Dividend yield  0.00%
     During the first nine monthsquarter of fiscal 2005, the Company did not issue any stock options to employees. Discontinued operations loss per share would not have changed asthat required the fair value calculation. The fair value of each outstanding option award in prior years was estimated on the date of grant using a result of stock-based compensation expense.
4. Inventories, Net
         
  August 31,  November 30, 
  2005  2004 
  (in millions) 
Long-term contracts at average cost $284  $235 
Raw materials and supplies  4   2 
Progress payments  (94)  (78)
       
Inventories, net $194  $159 
       
Black-Scholes Model. Assumptions used in the model for the prior year grants are described in the Company’s Annual Report on Form 10-K.
     During fiscal 2004,Expected Term:The Company’s expected term represents the Company recorded an inventory write-downperiod that the Company’s stock-based awards are expected to be outstanding and was determined based on historical experience of $16 million on a contract to design, develop and produce a solid rocket motor for Lockheed Martin’s Atlas® V program. This write-down relates to unanticipated transition costs from the development phasesimilar awards, giving consideration to the production phasecontractual terms of the contractstock-based awards and thevesting schedules.
Expected Volatility:The fair value of materials rendered obsolete bystock based payments were valued using the Black-Scholes Model with a decision to proceed with qualification and production of an enhanced motor configuration. In management’s judgment, these costs will not be recoverablevolatility factor based on the contract.Company’s historical stock prices. The range of expected volatility used in the Black-Scholes Model was 36% to 47%.
     Expected Dividend:The current contract with Lockheed provides for productionBlack-Scholes Model requires a single expected dividend yield as an input. The Company’s Board of 44 motors over a numberDirectors eliminated the payment of years and forquarterly dividends in the order of an additional 52 motors at Lockheed Martin’s option. At August 31, 2005, the Atlas V inventory balance was $165 million. Full recovery of this investment is subject to uncertainties, including: (i) the Company’s ability to produce motors at its estimated average unit price, (ii) final pricing of the enhanced motor configuration, and (iii) a satisfactory renegotiation of contract terms with Lockheed Martin. The Company believes its Atlas V contract will be restructured during the fourththird quarter of fiscal 2005 when launch services contracts between launch vehicle manufacturers2004 and beginning in December 2004, the senior credit facility restricted the payment of dividends. The Company does not anticipate paying any dividends in the near future.
Risk-Free Interest Rate: The Company bases the risk-free interest rate used in the Black-Scholes Model on the implied yield currently available on U.S. government are modifiedTreasury zero-coupon issues with an equivalent remaining term. The range of risk-free interest rates used in the Black-Scholes Model was 4.59% to reflect cost pressures resulting from continued low commercial launch activity. Details of the form and terms of the anticipated changes are unknown at this time. Management believes that continued improvements in operational efficiency and renegotiation of contract terms will permit recovery of inventoried4.67%.

812


development and production costs. However, if management’s efforts are unsuccessful,Estimated Pre-vesting Forfeitures:When estimating forfeitures, the Company mayconsiders historical termination as well as anticipated retirements.
4. Accounts Receivable
         
  February 28,  November 30, 
  2006  2005 
  (in millions) 
Receivables under long-term contracts:        
Billed $46.8  $45.4 
Unbilled costs and estimated earnings  27.0   36.7 
       
Accounts receivable $73.8  $82.1 
       
     The unbilled receivable amounts as of February 28, 2006 and November 30, 2005 expected to be required to recognize additional material losses.collected after one year were $2.9 million and $2.7 million, respectively. Such amounts are billed either upon delivery of completed units or settlements of contracts.
5. Inventories
         
  February 28,  November 30, 
  2006  2005 
  (in millions) 
Raw materials and supplies $2.5  $1.9 
Work in progress on commercial products  4.3   3.0 
Finished goods on commercial products  0.1   0.2 
Long-term contracts at average cost  117.5   86.1 
Progress payments  (51.2)  (33.7)
       
Inventories $73.2  $57.5 
       
6. Property, Plant and Equipment, Net
                
 August 31, November 30,  February 28, November 30, 
 2005 2004  2006 2005 
 (in millions)  (in millions) 
Land $29 $29  $29.3 $29.3 
Buildings and improvements 134 128  135.5 135.3 
Machinery and equipment 343 333  350.7 346.5 
Construction-in-progress 7 15  9.0 10.9 
          
 513 505  524.5 522.0 
Less: accumulated depreciation  (376)  (360)  (387.2)  (381.8)
          
Property, plant and equipment, net $137 $145  $137.3 $140.2 
          

13


6.7. Other Noncurrent Assets, Net
                
 August 31, November 30,  February 28, November 30, 
 2005 2004  2006 2005 
 (in millions)  (in millions) 
Real estate held for development and leasing $30 $27 
Other receivables 23 23 
Note receivable $25.5 $25.5 
Other receivable 26.4 26.4 
Real estate held for entitlement and leasing 33.1 32.3 
Deferred financing costs 17 21  16.6 16.4 
Other 28 21  22.1 27.4 
          
 123.7 128.0 
Less: allowance on note receivable  (25.5)  (25.5)
     
Other noncurrent assets, net $98 $92  $98.2 $102.5 
          
     As of August 31, 2005February 28, 2006 and November 30, 2004,2005, the Company had a receivable of $23$26.4 million from Northrop Grumman Corporation for amounts due related to environmental remediation (See(see Note 9(c)10 (c)).
     On November 30, 2005, the Company received a $25.5 million unsecured subordinated note receivable from American Pacific Corporation in connection with sale of the Company’s Fine Chemicals business (see Note 14). The Company amortizes deferred financing costs overrecorded a full valuation allowance on the term of the related debt.note.
7.8. Other Current Liabilities
                
 August 31, November 30,  February 28, November 30, 
 2005 2004  2006 2005 
 (in millions)  (in millions) 
Accrued goods and services $4.0 $4.8 
Contract loss provisions 9.0 10.0 
Advanced payments on contracts 51.7 44.8 
Accrued compensation and employee benefits $37 $37  40.2 41.1 
Advanced payments on contracts 27 22 
Contract loss provisions 12 15 
Accrued goods and services 4 11 
Interest payable 3 8  2.5 5.2 
Customer reimbursements of tax recoveries 13.0 13.0 
Other 51 48  24.7 23.6 
          
Other current liabilities $134 $141  $145.1 $142.5 
          
     Customer reimbursements of tax recoveries relate to a unitary tax settlement. Payment of this settlement was made during the second quarter of fiscal 2006.

914


8.9. Long-term Debt
         
  August 31,  November 30, 
  2005  2004 
  (in millions) 
Convertible subordinated notes, bearing interest at 5.75% per annum, interest payments due in April and October, maturing in 2007 (5 ¾% Notes) $20  $80 
Contingent convertible subordinated notes, bearing interest at 4.00% per annum, interest payments due in January and July, maturing in 2024 (4% Notes)  125   125 
Convertible subordinated debentures, bearing interest at 2.25% per annum, interest payments due in May and November, maturing in 2024 (2 ¼% Debentures)  146   80 
       
Total convertible subordinated notes  291   285 
       
Senior subordinated notes, bearing interest at 9.50% per annum, interest payments due in February and August, maturing in 2013 (9 ½% Notes)  98   150 
       
Total senior subordinated notes  98   150 
       
Term loan A, bearing interest at various rates (5.1% as of November 30, 2004)     28 
Term loan B, bearing interest at various rates (6.02% as of November 30, 2004)     113 
Term loan, bearing interest at various rates (rate of 6.86% as of August 31, 2005), payable in quarterly installments of approximately $250,000 plus interest, maturing in 2010  24    
Revolver Credit Facility, bearing interest on borrowed amounts at various rates (6.17% as of August 31, 2005) maturing in 2009  10    
Other  1   1 
       
Total other debt, including current portion  35   142 
       
Total debt  424   577 
Less: Amounts due within one year  (2)  (23)
       
Total long-term debt $422  $554 
       
         
  February 28,  November 30, 
  2006  2005 
  (in millions) 
Convertible subordinated notes, bearing interest at 5.75% per annum, interest payments due in April and October, maturing in 2007 (53/4% Notes)
 $19.8  $19.8 
Contingent convertible subordinated notes, bearing interest at 4.00% per annum, interest payments due in January and July, maturing in 2024 (4% Notes)  125.0   125.0 
Convertible subordinated debentures, bearing interest at 2.25% per annum, interest payments due in May and November, maturing in 2024 (21/4% Debentures)
  146.4   146.4 
       
Total convertible subordinated notes  291.2   291.2 
       
Senior subordinated notes, bearing interest at 9.50% per annum, interest payments due in February and August, maturing in 2013 (91/2% Notes)
  97.5   97.5 
       
Total senior subordinated notes  97.5   97.5 
       
Other debt  0.1   0.4 
Term loan, bearing interest at various rates (rate of 8.06% as of February 28, 2006), payable in quarterly installments of $250,000 plus interest, maturing in 2010  54.5   54.8 
       
Total other debt  54.6   55.2 
       
Total debt  443.3   443.9 
Less: Amounts due within one year  (1.1)  (1.4)
       
Total long-term debt $442.2  $442.5 
       
     The estimated fair value of the Company’s total debt was $490$508.7 million as of August 31, 2005February 28, 2006 compared to a carrying value of $424$443.3 million. The fair value of the convertible subordinated notes and the senior subordinated notes was determined based on quoted market prices as of August 31, 2005.February 28, 2006. The fair value of the remaining debt approximates the carrying value. InterestThe interest rates on such remaining debt are generally variable, based on market interest rates, and reflect market rates currently available to the Company.
a. Convertible Subordinated Notes
     In December 2004, an initial purchaser exercised its option to purchase additional2 ¼% Debentures totaling $66 million aggregate principal amount. Cash proceeds, net of underwriting discounts and transaction costs, were $64 million and were used to repurchase $60 million of the5 ¾% Notes, plus premium, accrued interest, and transaction costs.     The repurchase of the5 ¾% Notes resulted in an unusual charge of $5 million during the first quarter of fiscal 2005, including the write-off of deferred financing costs associated with the repurchased5 ¾% Notes.
     The holders of the 4% Notes had the right to convert their notes into GenCorp’s common stock during the calendar quarter ending September 30, 2005 (for the period July 1, 2005 through September 30, 2005) because the stock price contingent conversion condition was met in the calendar quarter ended June 30, 2005. The holders of the 4% Notes will also be able to convert their notes into GenCorp’s common stock for the period October 1, 2005 through December 31, 2005 because the stock price contingent was met in the calendar quarter ended September 30, 2005. Whether the notes will be convertible after September 30, 2005 will depend on the occurrence of events specified in the indenture governing the 4% Notes, including the market price of our common stock.
b. Senior Subordinated Notes
     In February 2005, the Company redeemed $52 million principal amount of its9 ½% Notes, representing 35% of the $150 million aggregate principal outstanding. In accordance with the indenture governing the notes, the redemption price was 109.5% of the principal amount of the9 ½% Notes redeemed, plus accrued and unpaid interest. The Company paid the redemption price using a portion of the restricted cash from the proceeds of the equity offering completed in November 2004, and recorded an unusual charge of $7 million in the first quarter of fiscal 2005, including the write-off of deferred financing costs associated with the redeemed9 ½% Notes.

10


c. Other Debt
     In December 2004, the Company entered into a new $180 million credit facility (New Credit Facility) with a syndicate of lenders. The New Credit Facility provides for an $80 milliona revolving credit facility (Revolver) maturing in December 2009, and a $100 million credit-linked facility maturing in December 2010. The2010; subject to early maturity in January 2007 if the 53/4% Notes remain outstanding or have not been cash collateralized by then. As of February 28, 2006, the credit-linked facility consistsconsisted of a $25$54.5 million term loan subfacility and a $75$44.3 million letter of credit subfacility. Interest rates are based on LIBOR borrowings or Alternate Base Rate borrowings, as defined in the Credit Agreement. The interest rate on the revolving credit facility is currently LIBOR plus 275225 basis points, or Alternate Base Rate plus 125 basis points, subject to adjustment based on the Company’s senior leverage ratio, with a minimum of 225 basis points andto a maximum of LIBOR plus 300 basis points, or Alternate Base Rate plus 200 basis points. The interest rate on the term loan isfor fiscal 2006 has been amended to be LIBOR plus 300325 basis points.points, or Alternate Base Rate plus 225 basis points, subject to a 50 basis point increase in the event that the Company’s senior secured debt ratings are lowered to certain levels. The fees on the letter of credit subfacility are 300for 2006 have also been amended to be 325 basis points plus any shortfall from LIBOR earned on the credit-linked deposits.deposits, subject to a 50 basis point increase in the event that the Company’s senior secured debt ratings are lowered to certain levels. The Revolver commitment fee is .5% per annum on the unused balance of the Revolver. As of August 31, 2005,February 28, 2006, the borrowing limit under the Revolver was $80$80.0 million of which the Company had zero outstanding borrowings of $10 million.borrowings. The Company also had $24$54.5 million outstanding on the term loan and $57$27.5 million outstanding letters of credit under the New Credit Facility. Cash proceeds from the term loan, net of underwriting fees and expenses associated with the New Credit Facility, were $21 million and were used for general corporate purposes.at February 28, 2006.
     The NewSenior Credit Facility is secured by substantially all of the Company’s assets, including the stock and assets of its material domestic subsidiaries whothat are guarantors of this facility. The Company is subject to certain limitations including the ability to: incur additional debt or sell assets, with restrictions on the use of proceeds; make certain investments and acquisitions; grant liens; and make restricted payments. The Company is also subject to financial covenants effective for the period ended August 31, 2005,as amended, which include an interest coverage ratio, fixed charge coverage ratio, a leverage ratio, and a senior leverage ratio. The fiscal 2005 financial covenants are as follows:
       
  Actual Ratios Required CovenantsRequired Covenants Dec. 1, 2005
Financial Covenant August 31, 2005February 28, 2006 Through November 30, 2005Dec. 1, 2005 Through Nov. 30, 2006
Interest coverage ratio 2.912.64 to 1.00 Not less than: 2.00 to 1.00 Not less than: 2.00 to 1.00
Fixed charge coverage ratio 1.152.03 to 1.00 Not less than: 1.10 to 1.00 Not less than: 1.15 to 1.00
Leverage ratio 6.386.24 to 1.00 Not greater than: 7.50 to 1.00Not greater than: 6.758.00 to 1.00
Senior leverage ratio 1.390.47 to 1.00 Not greater than: 2.50 to 1.00 Not greater than: 2.50 to 1.00

15


     Effective August 31, 2005,In January 2006, the Company entered into an Amendment to increase the maximum leverage covenant to 8.00 to 1.00 for fiscal 2006 and Waiver toincrease the Credit Agreement permittinginterest rate on the Company to provide seller financing in connection with the sale of the Fine Chemicals business and waived compliance with the Fixed Charge Coverage Ratio covenant for the period calculatedcredit linked facility as of August 31, 2005 due to the non-recurring investment for the Fine Chemicals business.discussed above. The Company was in compliance with its financial covenants as of August 31, 2005.
     The New Credit Facility replaces the previous credit facility (Restated Credit Facility), which was terminated by the Company in December 2004. The outstanding term loans totaling $141 million plus accrued interest under the Restated Credit Facility were repaid in full using restricted cash from the proceeds of the GDX Automotive sale completed in August 2004 and an equity offering completed in November 2004. The Company recorded an unusual charge of $6 million as a result of the termination of the Restated Credit Facility in the first quarter of fiscal 2005, representing the write-off of deferred financing costs.February 28, 2006.
9.10. Commitments and Contingencies
a. Legal proceedings
     From time to time, GenCorpthe Company and its subsidiaries are subject to legal proceedings, including litigation in federal and state courts, which arise out of, and are incidental to, the ordinary course of the Company’s on-going and historical businesses. The Company is also subject to governmental investigations by state and federal agencies. The Company cannot predict the outcome of such proceedings with any degree of certainty, and therefore as of August 31, 2005,February 28, 2006, except as noted below, an estimate of a probable loss or range of loss cannot be made. The potential liabilities that may result could have a material adverse effect on the Company’s financial position or the results of operations.
Groundwater Cases
     Along with other industrial Potentially Responsible Parties (PRPs) and area water purveyors, Aerojet was sued in three cases by approximately 500 individual plaintiffs residing in the vicinity of Aerojet’s facilities near Sacramento, California (the Sacramento cases). One of the cases was subsequently dismissed by the plaintiff. The remaining Sacramento cases are denominated as follows:Allen, et al. v. Aerojet-General Corporation, et al., Case No. 97AS06295, Sacramento County Superior Court, served January 14, 1998andSmith v. Aerojet-General Corporation, et al., Case No. 05AS01500, Sacramento County Superior Court, served August 14, 2005.
     The trial court determined that the Public Utility Commission regulated water purveyor defendants did not serve water in violation of state and federal standards. Accordingly, such regulated water entities were dismissed from the litigation. Aerojet is the sole defendant remaining in this litigation. The Sacramento Superior Court

11


through the initial pleading stage reduced the number of plaintiffs in the Sacramento cases to approximately 300. On or about May 28, 2004 and July 23, 2004, the Sacramento Superior Court dismissed, without leave to amend, nearly 250 plaintiffs, leaving the number of plaintiffs at 53. Subsequent dismissals, consolidation of another suit and a recent settlement with a group of plaintiffs have reduced the number of plaintiffs to 17.10. The remaining individual plaintiffs in the Sacramento cases generally seek damages for illness (in some cases death) and economic injury allegedly caused by their ingestion of groundwater contaminated or served by defendants,Aerojet and others, without specifying actual damages. Trial in the Sacramento cases has been set for December 2005.
     Aerojet was also suedcommenced in 14 cases by approximately 1,100 individual plaintiffs residing in the vicinity of Aerojet’s former facility in Azusa, California (the San Gabriel Valley cases). In the San Gabriel Valley cases, the number of plaintiffs had been reduced to approximately 500. The San Gabriel Valley cases, coordinated for trial in Los Angeles, California, had been proceeding under two master complaints. The remaining plaintiffs in the San Gabriel Valley cases generally sought damages for illness (in some cases death) and economic injury allegedly caused by their ingestion of groundwater contaminated or served by defendants, without specifying actual damages. Aerojet has recently agreed to settle the San Gabriel Valley cases and is working with plaintiffs’ counsel on appropriate settlement agreements and releases. The terms of such settlement are confidential.February 2006.
     Aerojet and other defendants were sued by the Orange County Water District, a public entity with jurisdiction over groundwater resources and water supplies in Orange County.County:Orange County Water District v. Northrop Corporation, et al.Case No. O4CC00715, Orange County (CA) Superior Court, served December 29, 2004. The plaintiff alleges that groundwater in Orange County, California is contaminated with chlorinated solvents that were allegedly released to the environment by Aerojet and other industrial defendants causing it to incur unspecified response costs and other damages. The plaintiff seeks declaratory relief and recovery of past costs in connection with investigation and remediation of groundwater resources. Discovery is ongoing.
Air Cases
     Aerojet, General Dynamics Ordnance and Tactical Systems (General Dynamics) and Olin Corporation were sued by residents living in the vicinity of Chino and Chino Hills, California. The cases have been consolidated and are pending in the U.S. District Court for the Central District of California.Baier, et al. v. Aerojet-General Corporation, et al., Case No. EDCV 00 618VAP (RNBx) CA;Kerr, et al. v. Aerojet-General Corporation, Case No. EDCV 01-19VAP (SGLx); andTaylor, et al. v. Aerojet-General Corporation, et al., Case No. EDCV 01-106 VAP (RNBx). An additional case involving similar allegations was filed in 2004.Yeh, et al. v. Aerojet-General Corporation,Case No. RCV 083065 San Bernardino County Superior Court (transferred to U.S. District Court, Central District, CA, renumbered Case No. EDCV 04-1354-VAP(SHx). This case was coordinated with the Baier, Kerr and Taylor cases (the Chino Hills cases). The Company is defending General Dynamics and Olin pursuant to contractual obligations associated with the prior sale of Aerojet’s Ordnance Division. Various motions reduced the number of plaintiffs from 80 to 48. Aerojet recently agreed to settle the Chino Hills cases and is working with plaintiffs’ counsel on appropriate settlement agreements and releases. The terms of such settlement are confidential.
Water Entity Cases
     In October 2002, Aerojet, along with approximately 65 other individual and corporate defendants, was served with four civil suits filed in the U.S. District Court for the Central District of California that seek recovery of costs allegedly incurred in response to the contamination present at the South El Monte Operable Unit (SEMOU) of the San Gabriel Valley Superfund site. The cases are denominated as follows:The City of Monterey Park v. Aerojet-General Corporation, et al., (CV-02-5909 ABC (RCx));San Gabriel Basin Water Quality Authority v. Aerojet-General Corporation, et al., (CV-02-4565 ABC (RCx));San Gabriel Valley Water Company v. Aerojet-General Corporation, et al., (CV-02-6346 ABC (RCx)) andSouthern California Water Company v. Aerojet-General Corporation, et al., (CV-02-6340 ABC (RCx)). The cases have been coordinated for ease of administration by the court. The plaintiffs’ claims are based upon allegations of discharges from a former site in the El Monte area, as more fully discussed below under the headings “San Gabriel Valley Basin, California — South El Monte Operable Unit.” The total cost estimate to implement projects under the Unilateral Administrative Order (UAO) prepared by the EPA and the water entities is approximately $90 million. Aerojet is vigorously defending the actions as its investigations do not identify a credible connection between the contaminants identified by the water entities in the SEMOU and those detected at Aerojet’s former facility located in El Monte, California, near the SEMOU (East Flair Drive site). Aerojet has filed third-party complaints against several water entities on the basis that they introduced perchlorate-containing Colorado River

16


water to the basin. Those water entities have filed motions to dismiss Aerojet’s complaints. The motions as well as discovery have been stayed pending efforts to resolve the litigation through mediation. Aerojet has notified its insurers of these claims.

12


GenCorp Inc. v. Olin Corporation
     In August 1991, Olin Corporation (Olin) advised the Company that under a 1962 manufacturing agreement with Olin (the 1962 Agreement), it believed GenCorp to be jointly and severally liable for certain Superfund remediation costs, estimated by Olin to be $70 million. The costs are associated with a former Olin manufacturing facility and its waste disposal sites in Ashtabula County, Ohio. In 1993, the Company sought a declaratory judgment in federal court (the Ohio Court) that it was not responsible for such environmental remediation costs.GenCorp Inc. v. Olin Corporation, Case No. 5:93CV2269, U.S. District Court, N.D. Ohio. Olin counterclaimed seeking a judgment that the Company was liable for a share of remediation costs. The Company argued that it was not derivatively or directly liable as an arranger for disposal of waste at the “Big D Campground” landfill (Big D site), both as a matter of fact and law. As a defense to Olin’s counterclaim, the Company asserted that under the terms of the 1962 Agreement, Olin had a contractual obligation to insure against environmental and other risks and that its failure to protect such insurance payments under these policies precluded Olin from recovery against the Company for these remediation costs. Further, the Company asserted that any failure on Olin’s part to comply with the terms of such insurance policies would result in the Company being entitled to breach of contract remedies resulting in a reduction in any CERCLA liability amounts determined to be owed to Olin that would have otherwise been recovered from Olin’s insurance carriers (the Reduction Claims).
     In 1999, the Ohio Court rendered an interim decision on CERCLA liability. The Ohio Court found GenCorp 30% liable and Olin 70% liable for remediation costs at the Big D site. The Ohio Court also found GenCorp 40% liable and Olin 60% liable for remediation costs, including costs for off-site disposal (other than the Big D site) and costs attributable to contamination at the Olin TDI facility, a plant built and operated by Olin on GenCorp property near the Big D site. However, the Ohio Court did not rule on the Company’s Reduction Claims and determined it would hold these claims in abeyance.
     In a related case, on August 27, 2002, the U.S. District Court for the Southern District of New York (the NY Court) ruled that Olin failed to protect its right to payments under its insurance policies for the Big D site. The NY Court based its ruling on the fact that Olin had failed to timely notify its insurance carriers of its claims. Given Olin’s contractual obligations and the NY Court’s finding that Olin failed to give proper notice of a claim under these insurance policies, management could not then, or at this time, estimate the possible amount of liability arising from this case, if any.
     Olin appealed the NY Court’s ruling to the Second Circuit Court of Appeals. In November 2003, the Second Circuit Court of Appeals vacated the NY Court’s decision with respect to Olin’s excess insurance carriers. While the Second Circuit Court of Appeals upheld the dismissal as to the primary carriers, it held that the NY Court failed to make a record sufficient to dismiss the excess carriers. Thus, the case was remanded to the NY Court for further proceedings. On further review, the NY Court may still decide that Olin’s notice to the excess insurance carriers was untimely or could decide it was timely.
     If the NY Court decides Olin’s notice was untimely, the Ohio Court could rule inGenCorp Inc. v. Olin Corporationthat Olin’s late notice constituted a breach of Olin’s obligation under the 1962 Agreement to protect the insurance; or it could conclude that Olin’s conduct does not support the Company’s Reduction Claims and thus does not reduce the Company’s liability. If the Ohio Court rules that Olin’s late notice is a breach of the 1962 Agreement, then it must determine the damages suffered by the Company as a result of the breach. The Company has argued that the proper measure of damages is the coverage limits of the policies that Olin forfeited — an amount in this case that is more than sufficient to cover the Company’s entire liability.
     On November 21, 2002, the Ohio Court issued a memorandum opinion and judgment entering “final” judgment in favor of Olin in the amount of approximately $19 million plus prejudgment interest in the amount of approximately $10 million. At that time, the Ohio Court did not decide the Company’s Reduction Claims against Olin. The Ohio Court held that the Company’s Reduction Claims “are held in abeyance pending the resolution of [Olin’s] appeal in the New York insurance litigation.”
     On January 22, 2003, the Ohio Court issued a judgment order stating the case was “terminated” on the Ohio Court’s docket. However, in its memorandum opinion and order of the same date, the Ohio Court stated “[w]hether there was an insurable event upon which Olin would have been entitled to recovery had it provided its insurers with timely notice . . . and . . . whether GenCorp is entitled to credit based upon Olin’s omission which foreclosed insurance recovery for Big D, remain unresolved.” Management believes that a recovery on the Company’s Reduction Claims could range from a nominal amount to an amount sufficient to reduce the judgment against the Company in its entirety.
     The Company appealed the Ohio Court’s ruling regarding CERCLA contribution liability to the Sixth Circuit Court of Appeals (the Court of Appeals).GenCorp Inc. v. Olin Corporation, Docket Nos. 03-3019; 03-3211, United States Court of Appeals for the Sixth Circuit. In that appeal, the Company argued that it was not directly or indirectly liable as an arranger for Olin’s waste disposal at

13


the Big D site and that it did not either actively control Olin’s waste disposal choices or operate the plant on a day-to-day basis. The Court of Appeals heard oral arguments on June 11, 2004. On November 22, 2004, the Court of Appeals issued its opinion ruling against the Company with respect to all of its major claims. Subsequently, the Company filed a petition for a rehearing en banc. On March 31, 2005, the Company received the decision of the Court of Appeals denying its petition. The Company has filed with the U.S. Supreme Court a petition for writ of certiorari. The Court of Appeals has agreed to stay its mandate pending the decision by the U.S. Supreme Court on the Company’s petition for writ of certiorari.
     The Reduction Claims portion of the case is on hold pending final resolution of the NY Court’s determination as to whether Olin’s notice to its insurance carriers was or was not timely. Irrespective of the outcome of its appeal, the Company believes it has contractual protection against Olin’s claims by virtue of Olin’s obligations to procure and protect insurance. The Ohio Court had previously stated that pursuant to the terms of the 1962 Agreement, it was Olin’s contractual obligation to obtain insurance coverage and the evidence adduced during the litigation showed that Olin had in place insurance coverage during the period in question in the amount of $40 million to $50 million.
     In summary, while the Ohio Court’s order finding the Company liable to Olin for a CERCLA contribution payment was upheld by the Sixth Circuit Court of Appeals, the Company has concluded it is not appropriate to accrue any additional amount related to that finding because: (a) the Company previously accrued the entire amount of its estimated potential liability for contamination at the Olin TDI facility and related offsite contamination, except for disposal at the Big D site; (b) the Company believes it has a strong basis for appeal on the grounds that it is not derivatively or directly liable as an arranger for disposal at the Big D site, both as a matter of fact and law and that a recent decision by the U.S. Supreme Court issued after the November 22, 2004 decision by the Court of Appeals raises the question as to whether Olin is entitled to contribution from the Company under CERCLA; and (c) irrespective of whether, upon exhausting all avenues of appeal, there is a finding of CERCLA liability, the Company believes that: (i) if Olin prevails in the NY Court action against its excess insurance carriers, the Company will ultimately benefit from available insurance proceeds and may make no payment to Olin; or (ii) if Olin fails in the action against its excess insurance carriers, that Olin’s breach of its contractual obligation to provide insurance will result in a reduction in, or elimination of, some or all of such liability. In any event, the possible amount of liability arising from this case or any reduction in the Company’s liability, if any, cannot be established at this time.
Tolwin et al. v. GenCorp Inc. et al.
     In November 2004, an alleged shareholder of the Company filed a lawsuit in Superior Court of the State of California, Sacramento County, against the Company, its directors and one executive officer.Tolwin et al. v. GenCorp Inc. et al. Plaintiff alleges that the defendants breached their fiduciary duties by failing to give adequate consideration to reasonable acquisition offers. Plaintiff sought class action status and on behalf of herself and other similarly situated individuals, plaintiff sought damages and injunctive relief. The defendants filed a motion for judgment on the pleadings, which was granted on February 17, 2005. The trial court granted plaintiff leave to amend the complaint. The defendants have notified their insurer and, if an amended complaint is filed, intend to vigorously defend this action.
Vinyl Chloride Toxic Tort CasesLitigation
     Between the early 1950s and 1985, the Company produced polyvinyl chloride (PVC) resin at its former Ashtabula, Ohio facility. PVC is one of the most common forms of plastic currently on the market. A building block compound of PVC is vinyl chloride (VC), now listed as a known carcinogen by several governmental agencies. The Occupational Safety and Health Administration (OSHA) has strictly regulated workplace exposure to VC since 1974.
     Since the mid-1990s, the Company has been named in 46 toxic tortnumerous cases involving alleged exposure to VC. WithIn the exceptionmajority of twosuch cases, brought by families of former Ashtabula employees, the Company is alleged to be a “supplier/manufacturer” of PVC and/or a civil co-conspirator with other VC and PVC manufacturers.manufacturers as a result of membership in a trade association. Plaintiffs generally allege that the Company and other defendants suppressed information about the carcinogenic risk of VC to industry workers, and placed VC or PVC into commerce without sufficient warnings. A few of these cases allegealleged VC exposure through various aerosol consumer products, in that VC had been used as an aerosol propellant during the 1960s. Defendants in these “aerosol” cases includeincluded numerous consumer product manufacturers, as well as the more than 30 chemical manufacturers. The Company used VC internally, but never supplied VC for aerosol or any other use.
     Of the total 47 cases that have been filed, 23the majority have been settleddismissed or dismissedsettled on terms favorable to the Company, including the cases where the Company was the employer. An additionalCompany. The eight cases have been dismissed but such cases may be re-filed in different jurisdictions. The 16 pending cases involve employees at VC or PVC facilities owned or operated by others, or allege aerosol exposure. One of the pending cases is a class action seeking a medical monitoring program for former employees at a PVC facility in

14


New Jersey. The complaints in each of these cases assert that the Company’s involvement in the alleged conspiracy stems from the Company’s membership in trade associations.
     Given the lack of any significant consistency to claims (i.e., as to product, operational site, or other relevant assertions) filed against the Company, the Company is unable to make a reasonable estimate of the future costs of pending claims or unasserted claims. Accordingly, no estimate of future liability has been accrued for such contingencies. The Company is vigorously defending against all claims in these cases.
Asbestos Litigation
     Over the years, the Company has from time to time been named as defendants in lawsuits alleging personal injury or death due to exposure to asbestos in building materials or in manufacturing operations. The majority have been filed in Madison County, Illinois and San Francisco, California. Since 1998, more than 100 of these asbestos lawsuits have been resolved, with the majority being dismissed and many being settled for less than $0.1 million each. Pursuant to an agreement with PCC Flow Technology, Inc. (PCC) pertaining to the operations of a former business, effective May 31, 2005, the Company assumed the defense of 30 asbestos related matters filed against PCC. Including the cases tendered by PCC, there were 107 asbestos cases pending as of August 31, 2005.
     Given the lack of any significant consistency to claims (i.e., as to product, operational site, or other relevant assertions) filed against the Company, the Company is unable to make a reasonable estimate of the future costs of pending claims or unasserted claims. Accordingly, no estimate of future liability has been accrued for such contingencies.
Asbestos Litigation
     The Company has from time to time been named as a defendant in lawsuits alleging personal injury or death due to exposure to asbestos in building materials, products or in manufacturing operations. The majority have been filed in Madison County, Illinois and San Francisco, California. Since 1998, more than 175 of these asbestos lawsuits have been resolved with the majority being dismissed. There were 155 asbestos cases pending as of February 28, 2006.
     Given the lack of any significant consistency to claims (i.e., as to product, operational site, or other relevant assertions) filed against the Company, the Company is unable to make a reasonable estimate of the future costs of pending claims or unasserted claims. Accordingly, no estimate of future liability has been accrued for such contingencies.
Other Legal Matters
     The Company is subject to other legal actions, governmental investigations and proceedings relating to a wide range of matters in addition to those discussed above. While there can be no certainty regarding the outcome of any litigation, investigation or proceeding, in the opinion of the Company’s management, after reviewing the information that is currently available with respect to such matters, any liability that may ultimately be incurred with respect to these matters is not expected to materially affect the Company’s consolidated financial condition. The effect of the resolution of these matters on the Company’s financial condition and results of operations, the Company’s liquidity and available financial resources cannot be predicted because any such effect depends on future results of operations, liquidity position and available financial resources, and the amount and timing of the resolution of such matters. In addition, it is possible that amounts could be significant in any particular reporting period.
b. Environmental Matters
Sacramento, California
     In 1989, a federal district court in California approved a Partial Consent Decree (Decree) requiring Aerojet to conduct a Remedial Investigation/Feasibility Study (RI/FS) of a portion of Aerojet’s Sacramento site. The Decree required Aerojet to prepare a RI/FS report on specific environmental conditions present at the site and alternatives available to remediate such conditions. Aerojet also is

17


required to pay for certain governmental oversight costs associated with Decree compliance. Beginning in the mid-1990s, the State of California expanded its surveillance of perchlorate and nitrosodimethylamine (NDMA). Under the RI/FS, traces of these chemicals were detected using new testing protocols in public water supply wells near Aerojet’s Sacramento site.
     Aerojet completed the initial phase of a site-wide remedial investigation in 1993. In addition, Aerojet has installed sixeight groundwater extraction and treatment facilities as interim or final measures to control groundwater contamination at the Sacramento site. Aerojet is also investigating groundwater contamination both on and off its facilities through the development of operable unit feasibility studies. On August 19, 2002, the EPA issued an administrative order requiring Aerojet to implement the EPA approved remedial action for the Western Groundwater Operable Unit. A nearly identical order was issued by the California Regional Water Quality Control Board, Central Valley (Central Valley RWQCB). In fiscal 2003, Aerojet discovered previously unidentified NDMA-contaminated groundwater located to the north and west of the Western Groundwater Operable Unit boundaries. Following such discovery, Aerojet undertook investigation to characterize the extent of the contamination. This investigation has been substantially completed. This contaminated groundwater zone has been incorporated into the Western Groundwater Operable Unit remediation plan. All Western Groundwater Operable Unit collection and treatment systems will be fully constructed in late 2006 or early 2007. Based on sampling, Aerojet believes that no municipal drinking water wells are threatened by this finding. Aerojet will continue to conductis conducting feasibility studies to refine technical approaches and costs to remediate the site. Remediation is underway at various site locations. The remediation costs are principally for design, construction, enhancement and operation of groundwater and soil treatment facilities, ongoing project management and regulatory

15


oversight. A discussion of Aerojet’s efforts to estimate these costs is contained below under the heading “Environmental Reserves and Estimated Recoveries.”
     On April 15, 2002, the United States District Court approved and entered a Stipulation and Order Modifying the Partial Consent Decree (Stipulation and Order). Among other things, the Stipulation and Order removed approximately 2,600 acres of Aerojet’s property from the requirements of the Decree and from the Superfund site designation, enabling Aerojet to put the 2,600 acres to more productive use. The Stipulation and Order (i) requiresrequired the Company to provide a guarantee of up to $75 million (in addition to a prior $20 million guarantee) to assure that remediation activities at the Sacramento site are fully funded; (ii) requiresrequired Aerojet to provide a short-term and long-term plan to replace lost water supplies; and (iii) dividesdivided the Superfund site into “Operable Units” to allow Aerojet and the regulatory agencies to more efficiently address and restore priority areas. Obligations under the $75 million aggregate guarantee are limited to $10 million in any year. Both the $75 million aggregate guarantee and the $10 million annual limitation are subject to adjustment annually for inflation.
     Aerojet leased the southern portion of the Sacramento site to Douglas Aircraft for rocket assembly and testing from 1957 to 1961 and sold approximately 3,800 acres, including the formerly leased portion, to Douglas Aircraft in 1961. Aerojet reacquired such property known as IRCTS from MDC, the successor to Douglas Aircraft and now an operating unit of The Boeing Company, in 1984.
     Both MDC and Aerojet were ordered to investigate and remediate environmental contamination by certain orders issued in 1991 and 1994 by the California Department of Toxic Substances Control (DTSC) and a similar 1997 order of the Central Valley RWQCB. In 1997, approximately 1,100 acres of the property were released from the DTSC orders, and in 2001, Aerojet sold such 1,100 acre property. Aerojet is actively remediating the remaining IRCTS property.
     In March 2004, the California Office of Environmental Health Hazard Assessment (OEHHA) established a perchlorate Public Health Goal at 6 parts per billion (ppb). The California Department of Health Services immediately established an Action Level for perchlorate at 6 ppb. The previous Action Level was 4 ppb. TheIn early 2005, the National Academy of Sciences (NAS) recently issued its report on the health effects of perchlorate, which report was designed to help policymakers set both federal and state standards for perchlorate in drinking water. The NAS report suggested a reference dose that translates into approximately 25 ppb. However, in April 2005, OEHHA decided to maintain the Public Health Goal at 6 ppb. California is in the process of establishing a drinking water standard for perchlorate.
San Gabriel Valley Basin, California
Baldwin Park Operable Unit
     Aerojet, through its former Azusa, California operations, was previously named by the U. S.U.S. Environmental Protection Agency (EPA) as a Potentially Responsible Party (PRP) for contamination in the portion of the San Gabriel Valley Superfund Site known as the Baldwin Park Operable Unit (BPOU).

18


     Between January 1995 and January 1997, the EPA issued Special Notice Letters to Aerojet and eighteen other companies requesting that they implement a groundwater remedy. Subsequently, perchlorate, NDMA, and 1,4-dioxane were identified as contaminants in the BPOU. On June 30, 2000, the EPA issued a UAO ordering the PRPs to implement a remedy consistent with the Record of Decision (ROD), but encouraging the PRPs to attempt to negotiate an agreement with the local purveyors. Aerojet, along with seven other PRPs (the Cooperating Respondents) signed a Project Agreement in late March 2002 with the Water Quality Authority, Watermaster, Valley County Water District, La Puente Valley Water District, San Gabriel Valley Water Company, Suburban Water Systems and California Domestic Water Company (the Water Entities). The Project Agreement, which has a term of 15 years, became effective on May 9, 2002. Pursuant to the Project Agreement, the Cooperating Respondents fund through an escrow account, the capital, operational, maintenance, and administrative costs of certain treatment and water distribution facilities to be owned and operated by the Water Entities. The Project Agreement also settled the past environmental claims of the Water Entities. There are also provisions in the Project Agreement for maintaining financial assurance (in the form of cash or letters of credit). When fully constructed, six treatment facilities will be treating in excess of 25,000 gallons per minute for the purposes of ROD implementation and providing a potable water supply. Aerojet and the other Cooperating Respondents have entered into an interim allocation agreement that establishes the interim payment obligations of Aerojet and the remaining Cooperating Respondents for the costs of the Project Agreement. Under the interim allocation, Aerojet is responsible for approximately two-thirds of all project costs, pending completion of any allocation proceeding. All project costs are subject to reallocation among the Cooperating Respondents. Aerojet intends to continue to defend itself vigorously to assure that it is appropriately treated with other PRPs and that costs of any remediation are properly allocated among all PRPs. Aerojet has notified its insurers and is pursuing claims under its insurance policies.

16


     A significant amount of public funding is available to offset project costs. To date, Congress has appropriated approximately $56 million (so called Title 16 or Dreier funds), which is potentially available for payment of project costs. All such funding will require Water Quality Authority (WQA) action to allocate funds to the project, which the WQA is currently considering. Approximately $34 million of the funding has been allocated to the project and additional funds may follow in later years.
     As part of Aerojet’s sale of its Electronics and Information Systems (EIS) business to Northrop Grumman Corporation (Northrop) in October 2001, the EPA approved a Prospective Purchaser Agreement with Northrop to absolve it of pre-closing liability for contamination caused by the Azusa facility, which liability will remain with Aerojet. As part of that agreement, GenCorp agreed to provide a $25 million guarantee of Aerojet’s obligations under the Project Agreement. As part of the EIS sale to Northrop, Aerojet paid the EPA $9 million which was an amount to be offset against Aerojet’s share of the EPA’s total claimed past costs (the EPA now claims total past costs attributable to various parties are approximately $28 million). Prior payments to the EPA bring the total payments to the EPA to approximately $9.5 million. Aerojet and the EPA have agreed to a final settlement for Aerojet’s portion of such past costs and haveentered into a Consent Decree under which Aerojet agreed to pay the United States approximately $1.65 million in two equal installments – half of which has already been paid with the balance due in twelve (12) months. The lawsuit (Case No. CV05-7516 CAS (RZx)) filed as a consent decree.prelude to the Consent Decree was subsequently dismissed. Unresolved at this time is the issue of California’s past costs which were last estimated at approximately $5 million.costs.
     In addition to the EPA’s UAO and the Project Agreement executed with the Water Entities, the California Regional Water Quality Control Board, Los Angeles Region (Los Angeles RWQCB) issued orders to Aerojet and other PRPs to conduct groundwater investigations on their respective sites (former Azusa, California site). As a result, the Los Angeles RWQCB ordered Aerojet to conduct limited soil vapor extraction, which Aerojet completed in 2003. Aerojet is awaiting approval from the Los Angeles RWQCB for the closure. The Los Angeles RWQCB also directed Aerojet to characterize perchlorate contamination in soils. Aerojet submitted a Remedial Action Plan (RAP) to the Los Angeles RWQCB and has begun implementing the activities recommended in the RAP. In addition, on January 11, 2005, Aerojet submitted a work plan to the Los Angeles RWQCB for additional soil characterization. Field work has been initiated by Aerojet. After consultation with the Los Angeles RQQCB,RWQCB, additional investigation activities are planned with respect to perchlorate-impacted soils.
South El Monte Operable Unit (SEMOU)
     On December 21, 2000, Aerojet received an order from the Los Angeles RWQCB requiring a work plan for investigation of Aerojet’s former El Monte facility. On January 22, 2001, Aerojet filed an appeal of the order with the Los Angeles RWQCB asserting selective enforcement. The appeal had been held in abeyance pending negotiations with the Los Angeles RWQCB, but due to a two-year limitation on the abeyance period, the appeal was dismissed without prejudice. On February 21, 2001, Aerojet received a General Notice Letter from the EPA Region IX naming Aerojet as a PRP with regard to the SEMOU of the San Gabriel Valley Superfund site. In September 2001, Aerojet submitted a limited work plan to the Los Angeles RWQCB.

19


     Aerojet continues to negotiate with the Los Angeles RWQCB regarding an investigation of this former facility and has agreed to a scope of work for additional field activities. Aerojet is currently implementingpreparing to implement the field work. In the event the Los Angeles RWQCB demands further site investigation, Aerojet may re-file its appeal.
     On April 1, 2002, Aerojet received a special notice letter from the EPA (dated March 28, 2002) that requested Aerojet to enter into negotiations with the EPA regarding the performance of a remedial design and remedial action for the SEMOU. In light of this letter, Aerojet performed a limited site investigation of the East Flair Drive Site. The data collected and summarized in the Field Investigation Report showed that chemicals including TCE and PCE were present in the soil and groundwater at and near the East Flair Drive Site. The Field Investigation Report also showed that the hydraulic gradient at the East Flair Drive Site is oriented toward the northeast.northeast and subsequent quarterly monitoring events continue to show an easterly/southeasterly gradient. This finding indicates that the site is not a likely source of contamination at the SEMOU, as the groundwater flow at the site is away from the SEMOU and not toward it. Given the data indicating that the East Flair Drive Site is not a source of the contamination at the SEMOU, Aerojet requested that the EPA reconsider its issuance of the SEMOU special notice letter.
     On August 29, 2003, the EPA issued a UAO against Aerojet and approximately 40 other parties requiring them to conduct the remedial design and remedial action in the SEMOU. The impact of the UAO on the recipients is not clear as much of the remedy is already being implemented by the water entities. The cost estimate to implement projects under the UAO prepared by the EPA and the water entities is approximately $90 million.
     The UAO requires the implementation of the Interim Record of Decision (IROD). The EPA extended the deadline for compliance with the UAO to allow the PRPs to resolve their liabilities with respect to SEMOU. In return, the EPA required the submission of a Good Faith Offer to implement the IROD. The Company has been working closely with the other PRPs to resolve this matter and submitted a Good Faith Offer to the EPA that was rejected on May 20, 2004. The EPA alleges that the Company, along with the other

17


UAO recipients, has failed to transmit a Good Faith Offer in compliance with its obligations under the UAO. The Company is working diligently with the EPA and the other PRPs to resolve this matter and insure compliance with the UAO.
     On November 17, 2005, Aerojet notified the Los Angeles RWQCB and EPA that a former Aerojet division at the site was involved in research and development at the site that included the use of 1,4-dioxane. This former division was divested in 1975, but it continued to operate at the former El Monte facility. Aerojet’s investigation is continuing.
     Aerojet has been served with civil suits filed in the U.S. District Court for the Central District of California by four public and private water companies. The suits seek recovery of costs allegedly incurred in response to the contamination present in the SEMOU. Plaintiffs allege that groundwater in the SEMOU is contaminated with chlorinated solvents and ammonium perchlorate that were released into the environment by Aerojet and other parties causing plaintiffs to incur unspecified response costs and other damages. Aerojet’s investigations to date have not identified a credible connection between the contaminants identified by the water entities in the SEMOU and those detected at Aerojet’s former facility located at 9100 and 9200 East Flair Drive, El Monte, California, which lies in or near the SEMOU.
     Aerojet was successful in its efforts to eliminate several of the claims initially raised by the water entities. However, other claims remain. Aerojet has filed third-party complaints against several water entities on the basis that they introduced perchlorate-containing Colorado River water to the basin. The water entities have filed motions to dismiss Aerojet’s complaints. Discovery and the motions have been stayed pending efforts to resolve the litigation through mediation.
Other Sites
     The Company has studied remediation alternatives for its closed Lawrence, Massachusetts facility, which was primarily contaminated with polychlorinated biphenyls, and has begun site remediation and off-site disposal of debris. As part of these remediation efforts, the Company is working with local, state and federal officials and regulatory agencies to return the property to a beneficial use. The time frame for the remediation and redevelopment project is currently estimated to range from two to three years.
     The Company is also currently involved in approximately 3735 other remediation actions. In many of these matters, the Company is involved with other PRPs. In many instances, the Company’s liability and proportionate share of costs have not been determined largely due to uncertainties as to the nature and extent of site conditions and the Company’s involvement. While government agencies frequently claim PRPs are jointly and severally liable at such sites, in the Company’s experience, interim and final allocations of liability costs are generally made based on relative contributions of waste. In the Company’s previous experience, the Company

20


allocated share has frequently been minimal, and in many instances, has been less than one percent. Also, the Company is seeking recovery of its costs from its insurers.
c. Environmental Reserves and Estimated Recoveries
Reserves
     The Company continually reviews estimated future remediation costs that could be incurred by the Company which take into consideration the investigative work and analysis of the Company’s engineers and the advice of its legal staff regarding the status and anticipated results of various administrative and legal proceedings. In most cases, only a range of reasonably possible costs can be estimated. In establishing the Company’s reserves, the most probable estimated amount is used when determinable and the minimum is used when no single amount is more probable. The timing of payment for estimated future environmental costs is subject to variability and depends on the timing of regulatory approvals for planned remedies and the construction and completion of the remedies.
     Quarterly, the Company performs a review of estimated future environmental costs which incorporates, but is not limited to the following: (i) status of work completed since the last estimate; (ii) expected cost savings related to the substitution of new remediation technology and to information not available previously; (iii) obligations for reimbursement of regulatory agency service costs; (iv) updated BPOU cost estimates; (v) costs of complying with the Western Groundwater Administrative Order, including replacement water and remediation upgrades at Aerojet’s Sacramento site; (vi) estimated costs related to IRCTS and Aerojet’s Sacramento site; (vii) new information related to the extent and location of previously unidentified contamination; and (viii) additional construction costs. The Company’s review of estimated future remediation costs resulted in a net increase in the Company’s future environmental costs of $2 million and $6 million for the three and nine months ended August 31, 2005, respectively.
     The effect of the final resolution of environmental matters and the Company’s obligations for environmental remediation and compliance cannot be accurately predicted due to the uncertainty concerning both the amount and timing of future expenditures and due to regulatory or technological changes. The Company believes, on the basis of presently available information, that the resolution of environmental matters and the Company’s obligations for environmental remediation and compliance will not have a material adverse effect on the Company’s results of operations, liquidity or financial condition. The Company will continue its efforts to

18


mitigate past and future costs through pursuit of claims for recoveries from insurance coverage and other PRPs and continued investigation of new and more cost effective remediation alternatives and associated technologies.
     A summary of the Company’s environmental reserve activity is shown below (in millions):below:
                
                 November 30, 2006 2006 February 28, 
 November 30, 2005 2005 August 31,  2005 Additions Expenditures 2006 
 2004 Additions Expenditures 2005  (in millions) 
Aerojet $287 $6 $(23) $270  $255.6 $3.4 $(8.6) $250.4 
Other Sites 17   (3) 14  12.4   (1.0) 11.4 
                  
Environmental Reserve $304 $6 $(26) $284  $268.0 $3.4 $(9.6) $261.8 
                  
     As of August 31, 2005,February 28, 2006, the Aerojet reserves include $162$151.8 million for the Sacramento site, $91$81.4 million for BPOU, and $17$17.2 million for other Aerojet sites.
Estimated Recoveries
     On January 12, 1999, Aerojet and the U.S. government implemented the October 1997 Agreement in Principle (Global Settlement) resolving certain prior environmental and facility disagreements, with retroactive effect to December 1, 1998. The Global Settlement covered all environmental contamination at the Sacramento and Azusa sites. Under the Global Settlement, Aerojet and the U.S. government resolved disagreements about an appropriate cost-sharing ratio. The Global Settlement provides that the cost-sharing ratio will continue for a number of years.
     Pursuant to the Global Settlement covering environmental costs associated with Aerojet’s Sacramento site and its former Azusa site, the Company can recover up to 88% of its environmental remediation costs for these sites through the establishment of prices for Aerojet’s products and services sold to the U.S. government. Allowable environmental costs are charged to these contracts as the costs are incurred. Aerojet’s mix of contracts can affect the actual reimbursement made by the U.S. government. Because these costs are recovered through forward-pricing arrangements, the ability of Aerojet to continue recovering these costs from the U.S. government

21


depends on Aerojet’s sustained business volume under U.S. government contracts and programs and the relative size of Aerojet’s commercial business. Due to the Global Settlement, the increase to the reserve of $6 million in the first nine months of fiscal 2005 resulted in a corresponding increase to the receivable and a net impact of $2 million in net loss.
     In conjunction with the sale of EIS, Aerojet entered into an agreement with Northrop whereby Aerojet will be reimbursed by Northrop for a portion of environmental expenditures eligible for recovery under the Global Settlement. Amounts reimbursed are subject to annual limitations, with excess amounts carrying over to subsequent periods, the total of which will not exceed $190 million over the term of the agreement, which ends in 2028. As of August 31, 2005, $151February 28, 2006, $145.5 million in potential future reimbursements were available over the remaining life of the agreement.
     As part of the acquisition of the Atlantic Research Corporation (ARC) propulsion business, Aerojet entered into an agreement with ARC pursuant to which Aerojet is responsible for up to $20 million, of which $18 million remains as of February 28, 2006, of costs (Pre-Close Environmental Costs) associated with environmental issues that arose prior to Aerojet’s acquisition of the ARC propulsion business. Pursuant to a separate agreement with the U.S. government which was entered into prior to closing of the ARC acquisition, these Pre-Close Environmental Costs will be treated as allowable overhead costs combined with Aerojet’s environmental costs under the Global Settlement, and will be recovered through the establishment of prices for Aerojet’s products and services sold to the U.S. government. These costs were allocated to all Aerojet operations (including the previously excluded Redmond, Washington operations) beginning in fiscal 2005.
     As a result of the ARC acquisition, Aerojet signed a Memorandum of Understanding with the U.S. government agreeing to key assumptions and conditions that preserved the original methodology used in recalculating the percentage split between Aerojet and Northrop. Aerojet presented a proposal to the U.S. government based on the Memorandum of Understanding and expects to complete an agreement in the near term.
10.11. Arrangements with Off-Balance Sheet Risk
     As of August 31, 2005,February 28, 2006, obligations required to be disclosed in accordance with Financial Accounting Standards Board (FASB)FASB Interpretation No. 45 (FIN 45),Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of the Indebtedness of Othersconsisted of:
$57     — $27.5 million in outstanding commercial letters of credit expiring in fiscal 20052007 and fiscal 2006 securing obligations for environmental remediation and insurance coverage,coverage.
     — Up to $120.0 million aggregate in guarantees by GenCorp of Aerojet’s obligations to government agencies for environmental remediation activities.
     — Guarantees, jointly and litigation.severally, by the Company’s material domestic subsidiaries of its obligations under its senior credit facilities and its 91/2% Notes.
     In addition to the items discussed above, the Company from time to time enters into certain types of contracts that contingently require the Company to indemnify parties against third-party and other claims. These contracts primarily relate to: (i) divestiture agreements, under which the Company may provide customary indemnifications to purchasers of the Company’s businesses or assets including, for example, claims arising from the operation of the businesses prior to disposition, liability to investigate and remediate environmental contamination existing prior to disposition; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for other claims arising from the Company’s use of the applicable premises; and, (iii) certain agreements with the Company’s officers and directors, under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship.
     The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, the Company has not been obligated to make significant payments for these obligations, and no liabilities have been recorded for these obligations on its balance sheet as of February 28, 2006 and November 30, 2005.

1922


Up to $120 million aggregate in guarantees by GenCorp Inc. of Aerojet’s obligations to government agencies for environmental remediation activities.
Guarantees, jointly and severally, by the Company’s material domestic subsidiaries of its obligations under its senior credit facilities and its 9 ½% Notes.
11.12. Other Comprehensive Loss, Net of Income Taxes
     The Company’s other comprehensive loss consists of the accumulated effects of foreign currency translation adjustments, changes in the minimum funding liability for pension obligations, and changes in the fair value of certain derivative financial instruments, and changes in the minimum funding liability for pension obligations, if any. The effects of foreign currency translation adjustments have been primarily associated with the GDX business which was divested during the third quarter of fiscal 2004 (see Note 13).
     The components of other comprehensive loss and the related income tax effects are presented in the following table:
                 
  Three months ended August 31,  Nine months ended August 31, 
  2005  2004  2005  2004 
  (in millions) 
Net loss $(29) $(47) $(54) $(378)
Other comprehensive loss, net of income taxes:                
Effects of foreign currency translation adjustments     (34)  2   (35)
Change in minimum pension liability     2      2 
Change in fair value of interest rate swap           1 
Reclassification adjustment     33      33 
             
Total comprehensive loss $(29) $(46) $(52) $(377)
             
         
  Three months ended 
  February 28,  February 28, 
  2006  2005 
  (in millions) 
Net loss $(16.0) $(31.4)
Other comprehensive income, net of income taxes:        
Changes in the fair value of derivative financial instruments and other     0.2 
       
Total comprehensive loss $(16.0) $(31.2)
       
12. Employee Pension and Postretirement Plans13. Retirement Benefits
Pension Benefits The Company has defined benefit pension plans covering substantially all salaried and hourly domestic employees. Normal retirement age is 65, but certain plan provisions allow for earlier retirement. The Company’s funding policy complies with the funding requirements of applicable laws and regulations. Pension benefits are calculated under formulas principally based on average earnings and length of service for salaried employees and under negotiated non-wage based formulas for hourly employees.
     In addition to providing pension benefits, thePostretirement Medical and Life Benefits— The Company provides healthcaremedical and life insurance benefits (postretirement benefits) to certain domesticeligible retired employees, with varied coverage by employee group. Generally, employees hired after January 1, 1997 are not eligible for postretirement healthcareMedical and life insurance benefits. The healthcare plans generally provide for cost sharing between the Company and eligible retirees in the form of retiree contributions, deductibles and coinsurance. Postretirement benefit obligations are unfunded, and costs are accrued based on the date employees become eligible for benefits.unfunded.

20


     The componentsComponents of continuing operations net periodic benefit (income) expense for pension benefits and other postretirement benefits for the three and nine months ended August 31, 2005 and August 31, 2004 were comprised of:continuing operations are as follows:
                 
  Defined Benefit  Other Postretirement 
  Pension Plans  Benefit Plans 
  Three months ended August 31, 
  2005  2004  2005  2004 
  (in millions) 
Service cost $3  $3  $2  $ 
Interest cost on benefit obligation  29   28      3 
Assumed return on plan assets  (34)  (34)      
Amortization of unrecognized prior service cost        (1)  (1)
Amortization of unrecognized net (gains) losses  14   13   (1)   
             
Net periodic benefit expense $12  $10  $  $2 
             
                                
 Defined Benefit Other Postretirement  Pension Benefits Postretirement Benefits 
 Pension Plans Benefit Plans  Three months ended   
 Nine months ended August 31,  February 28, February 28, February 28, February 28, 
 2005 2004 2005 2004  2006 2005 2006 2005 
 (in millions)  (in millions) 
Service cost $10 $9 $ $  $4.5 $3.4 $0.1 $0.1 
Interest cost on benefit obligation 86 84 5 8  28.3 28.5 1.4 1.8 
Assumed return on plan assets  (100)  (101)     (34.7)  (33.5)   
Amortization of unrecognized prior service cost 1 1  (2)  (3) 0.6 0.4  (0.8)  (1.0)
Amortization of unrecognized net (gains) losses 41 37  (5) 1  13.2 13.8  (1.6)  (1.6)
Amortization of transition obligations   (1)   
                  
Net periodic benefit (income) expense $38 $29 $(2) $6  $11.9 $12.6 $(0.9) $(0.7)
                  
     During the three and nine months ended August 31,first quarter of fiscal 2005, discontinued operations incurred less than $1$0.1 million of net periodic expense for pension and other postretirement benefits. During the three and nine months ended August 31, 2004, discontinued operations incurred $12 million and $19 million, respectively, of net periodic expense for pension and other postretirement benefits including $10 million related to the curtailment and settlement expenses from the completion of the sale of the GDX business.

23


     The Company has two significant defined benefit pension plans which were merged effective August 31, 2005. The merger provides economies in the administrative functions, may reduce volatility of future contributions to the plan, if any, and eliminates a charge to shareholders’ equity as of November 30, 2005 due to a shortfall of assets in one of the plans prior to the merger caused primarily from the decline in interest rates over the past 12 months. Adjustments to shareholders’ equity in the future could be required based on future market returns on plan assets and changes in interest rates.
     During the second quarter of fiscal 2005, the Company recorded an estimated legal settlement charge of less than one million dollars related to theWotus, et al. v. GenCorp Inc. et al.case. The remaining estimated retiree medical costs of the settlement of $12 million to $18 million will be accounted for as a plan amendment pursuant to SFAS 106,Employer’s Accounting for Postretirement Benefits Other Than Pensions,and amortized over a period of years.
     During the third quarter of fiscal 2005, the Company announced an amendment to its retiree medical plan for salaried retirees and certain hourly retirees. Under the plan amendment, effective January 1, 2006, the Company is reducing its obligations for those retirees eligible for coverage under a Company-sponsored national plan which will integrate with Medicare Part D. The estimated decrease in the benefit obligation of approximately $10 million to $20 million will be accounted for as a plan amendment pursuant to SFAS 106, and amortized over a period of years.
13.14. Discontinued Operations
     During the second quarter of fiscal 2004, the Company announced plans to sell the GDX business. This decision was a result of declining volumes and continued challenges in this market environment including increased material costs, high development and start-up costs, anticipated working capital requirements as well as adverse customer pricing pressures. In accordance with the Company’s plan to sell the GDX business, the GDX operating segment was classified as a discontinued operation during the second quarter of fiscal 2004.     During the third quarter of fiscal 2004, the Company classified the Fine Chemicals segment as a discontinued operation as a result of its plans to sell the business. The plan was a result of management’s decision to focus its capital and resources on its Aerospace and Defense and Real Estate operating segments. In July 2005, the Company signed a definitive agreement to sell GDX, including substantially allthe Fine Chemicals business to American Pacific Corporation (AMPAC) for $119 million, consisting of $100 million of cash, seller note of $19 million, and the assetsassumption by the buyer of GenCorp Inc. that were usedcertain liabilities. Subsequently, AMPAC and the Company amended the purchase agreement to modify the purchase price and payment terms related to the Fine Chemicals sale. The revised purchase price consisted of $88.5 million of cash paid at closing, unsecured subordinated seller note of $25.5 million delivered at closing, a contingent payment of up to $5.0 million if the Fine Chemicals business achieves specified earning targets in the GDX businesstwelve month period ending September 30, 2006, and substantially allthe assumption by the buyer of GenCorp Inc.’s worldwide

21


subsidiaries that were engagedcertain liabilities. Income will be recorded in the GDX business, to Cerberus Capital Management, L.P. for $147future on the seller note and any contingent payment when realized. During fiscal 2005, the Company recorded a loss of $28.7 million subject to adjustment, of which $140 million was received as of August 31, 2005. The Company closedon the transaction on August 31, 2004. For operating segment reporting, GDX was previously reported as a separate operating segment.
     During the second quarter of fiscal 2004, the GDX operating segment net assets were adjusted to management’s estimate ofdifference between estimated cash proceeds to be received on disposition less costs to sell that resulted in a $261 million lossthe carrying value of net assets being recorded.sold and related transaction selling costs. An additional loss of $18$0.1 million was recorded in the thirdfirst quarter of fiscal 20042006 to reflect the net assets of the GDXFine Chemicals business and management’s estimate of the proceeds from the sale ofsale. The Company closed the GDXtransaction on November 30, 2005. For operating segment reporting, the Fine Chemicals business to Cerberus.was previously reported as a separate operating segment.
     In November 2003, the Company announced the closing of a GDX manufacturing facility in Chartres, France. The decision resulted primarily from declining sales volumes with French automobile manufacturers. In June 2004, the Company completed the legal process for closing the facility and establishing a social plan. In fiscal 2004,2005, an expense of approximately $14$1.0 million related to employee social costs was recorded in accordance with SFAS No. 146,Accounting for Costs Associated with Exit or Disposal Activities. An expense of $1 million was recorded during the first nine months of fiscal 2005 primarily related to employee social costs that became estimable in the first nine months of fiscal 2005 and is included as a component of discontinued operations. The Company has not yet recorded expenses associated with certain social benefits due to the uncertainty of the benefit amount. These additional social costs are expected tomay result in an additional pre-tax expense of up to $2$2.0 million and are anticipated to be incurred over the next 12 months to 15 months.
     During the third quarter of fiscal 2004, the Company classified the Fine Chemicals segment as a discontinued operation as a result of its plans to sell the business. This plan was a result of management’s decision to focus its capital and resources on its Aerospace and Defense and Real Estate operating segments. In July 2005, the Company announced its plan to sell the Fine Chemicals business to American Pacific Corporation for $119 million, consisting of $100 million of cash, seller note of $19 million, and the assumption by the buyer of certain liabilities. American Pacific Corporation and the Company recently agreed to amend the purchase agreement to modify the sale price and payment terms related to the Fine Chemicals sale. The revised purchase price consists of $89 million of cash payable at closing, seller note of $25 million delivered at closing, a contingent payment of up to $5 million if Fine Chemicals achieves specified earning targets in the twelve month period ending September 30, 2006, and the assumption by the buyer of certain liabilities. The Company has recorded a loss of $28 million in the third quarter based on the difference between current estimated cash proceeds to be received on disposition less the carrying value of net assets being sold and related transaction selling costs. Income will be recorded in the future on the seller note of $25 million and any contingent payment when realized. The Company continues to expect the transaction to close in October 2005. For operating segment reporting, the Fine Chemicals business was previously reported as a separate operating segment.
     In accordance with EITF 87-24,Allocation of Interest to Discontinued Operations, the Company allocated interest to discontinued operations based on interest on debt that would be required to be repaid using estimated proceeds to be received from the sale of the GDX Automotive business and the anticipated sale of the Fine Chemicals business. This allocation resulted in interest of less than $1 million in the third quarter of fiscal 2005 and $1 million for the third quarter of fiscal 2004. Interest allocation for the first nine months of fiscal 2005 and fiscal 2004 was $1 million and $4 million, respectively.

22


     Summarized financial information for the GDX and Fine Chemicalsdiscontinued operations is set forth below:
        
                 Three months ended 
 Three months ended August 31, Nine months ended August 31,  February 28, February 28, 
 2005 2004 2005 2004  2006 2005 
 (in millions)  (in millions) 
Net sales $18 $191 $41 $605  $ $10.0 
Loss before income taxes  (24)  (33)  (25)  (308)  (0.9)  (1.4)
Income tax benefit  1  2 
Net loss from discontinued operations  (24)  (32)  (25)  (306)
Income tax provision   
Loss from discontinued operations, net of income taxes  (0.9)  (1.4)
     As of August 31, 2005February 28, 2006 and November 30, 2004,2005, the components of assets and liabilities of discontinued operations in the consolidated balance sheets are as follows:
         
  August 31,  November 30, 
  2005  2004 
  (in millions) 
Accounts receivable, net $14  $8 
Inventories, net  20   10 
Other assets  3   3 
Property, plant and equipment, net  73   73 
       
Assets of discontinued operations $110  $94 
       
         
Accounts payable and other liabilities $26  $18 
       
Liabilities of discontinued operations $26  $18 
       
         
  February 28,  November 30, 
  2006  2005 
  (in millions) 
Accounts payable $1.0  $0.9 
Other liabilities  0.8   1.0 
       
Liabilities of discontinued operations $1.8  $1.9 
       
14.15. Operating Segments and Related Disclosures
     The Company’s management decided to divest the GDX and the Fine Chemicals businesses during fiscal 2004 (See Note 13). These businesses, which were previously considered separate operating segments, have been classified as discontinued operations. As a result, the Company’s continuing operations are now organized into two operating segments based on different products and customer bases: Aerospace and Defense and Real Estate.
     The Company evaluates its operating segments based on several factors, of which the primary financial measure is segment performance. Segment performance represents net sales from continuing operations less applicable costs, expenses and provisions for unusual items relating to operations. Segment performance excludes corporate income and expenses, provisions for unusual items not related to the operations, interest expense and income taxes (see Note 1516 for a discussion on unusual items).

24


     During the three months ended August 31,first quarter of fiscal 2006, Lockheed Martin and Raytheon accounted for 39% and 17%, respectively, of net sales. During the first quarter of fiscal 2005, Lockheed Martin and Raytheon accounted for 34%37% and 16%, respectively, of net sales. During the nine months ended August 31, 2005, Lockheed Martin and Raytheon accounted for 35% and 18%, respectively, of net sales. During the three months ended August 31, 2004, Lockheed Martin, Raytheon, and Boeing accounted for 35%, 17%, and 10%, respectively, of net sales. During the nine months ended August 31, 2004, Lockheed Martin, Raytheon, and Boeing accounted for 31%, 16%, and 11%19%, respectively, of net sales. Sales duringin the threefirst quarter of fiscal 2006 and nine months ended August 31,fiscal 2005 directly and indirectly to the U.S. government and its agencies, including sales to the Company’s significant customers discussed above, totaled $111 million75% and $351 million, respectively. Sales during the three and nine months ended August 31, 2004 directly and indirectly to the U.S. government and its agencies, including sales to the Company’s significant customers discussed above, totaled $99 million and $299 million, respectively.86%, respectively, of net sales.

23


     Selected financial information for each reportable segment is as follows:
                 
  Three months ended August 31,  Nine months ended August 31, 
  2005  2004  2005  2004 
  (in millions) 
Net Sales:
                
Aerospace and Defense $132  $116  $416  $354 
Real Estate  2   2   5   4 
Intersegment sales elimination     (2)     (8)
             
Total
 $134  $116  $421  $350 
             
Segment Performance:
                
Aerospace and Defense $16  $18  $43  $44 
Retirement benefit plan expense  (9)  (7)  (26)  (21)
Unusual items        (2)   
             
Aerospace and Defense Total
  7   11   15   23 
Real Estate
  1   1   3   3 
             
Total
 $8  $12  $18  $26 
             
Reconciliation of segment performance to loss from continuing operations before income taxes:
                
Segment Performance $8  $12  $18  $26 
Interest expense  (6)  (9)  (19)  (25)
Corporate retirement benefit plan expense  (3)  (5)  (10)  (14)
Corporate and other expenses  (4)  (10)  (13)  (26)
Unusual items        (18)   
             
Loss from continuing operations before income taxes
 $(5) $(12) $(42) $(39)
             
         
  August 31,  November 30, 
  2005  2004 
  (in millions) 
Assets:
        
Aerospace and Defense $951  $943 
Real Estate  41   37 
       
Identifiable assets  992   980 
Corporate  140   421 
Discontinued operations  110   94 
       
Total assets
 $1,242  $1,495 
       
         
  Three Months ended 
  February 28,  February 28, 
  2006  2005 
  (in millions) 
Net Sales:
        
Aerospace and Defense $127.2  $138.2 
Real Estate  1.5   1.7 
       
Total $128.7  $139.9 
       
Segment Performance:
        
Aerospace and Defense $8.2  $10.2 
Retirement benefit plan expense  (8.7)  (8.6)
       
Aerospace and Defense Total  (0.5)  1.6 
Real Estate  0.8   1.0 
       
Total $0.3  $2.6 
       
Reconciliation of segment performance to loss from continuing operations before income taxes and cumulative effect of a change in accounting principle:
        
Segment Performance $0.3  $2.6 
Interest expense  (6.3)  (7.1)
Corporate retirement benefit plan expense  (2.3)  (3.3)
Corporate and other expenses  (5.5)  (4.1)
Unusual items     (18.1)
       
Loss from continuing operations before income taxes and cumulative effect of a change in accounting principle $(13.8) $(30.0)
       
15.16. Unusual items
     Charges associated with unusual items for the first nine monthsquarter of fiscal 2005 arewere as follows (in millions):
     
Aerospace and Defense:
    
Unrecoverable portion of legal settlement $2 
    
   2 
Corporate Headquarters:
    
Loss on redemption of 9 ½% Notes  7 
Loss on repayment of 5 ¾% Notes  5 
Loss on termination of the Restated Credit Facility  6 
    
   18 
    
Unusual expense $20 
    
     
Loss on redemption of 91/2% Notes
 $6.7 
Loss on repayment of 53/4% Notes
  5.5 
Loss on termination of the Restated Credit Facility  5.9 
    
Unusual expense $18.1 
    
     In the first quarter of fiscal 2005, the Company recorded a charge of $18$18.1 million as a result of the termination of the Restated Credit Facility, the redemption of $52$52.5 million of principal of the 9 ½%1/2% Notes, and the repayment of $60$59.9 million of principal of the 5 ¾% Notes, and the termination of the Restated Credit Facility.3/4% Notes.
     In the second quarter of fiscal 2005, Aerojet recorded a charge of $2 million related to an estimated legal settlement of the San Gabriel Valley and Chino Hills toxic tort cases (see Note 9(a) for additional information).

24


16.17. Condensed Consolidating Financial Information
     The Company is providing condensed consolidating financial information for its material domestic subsidiaries that have guaranteed the Senior Subordinated Notes, and for those subsidiaries that have not guaranteed the Senior Subordinated Notes. These 100% owned subsidiary guarantors have, jointly and severally, fully and unconditionally guaranteed the Senior Subordinated Notes. The subsidiary guarantees are senior subordinated obligations of each subsidiary guarantor and rank (i) junior in right of payment with all senior indebtedness, (ii) equal in right of payment with all senior subordinated indebtedness and (iii) senior in right of payment to all subordinated indebtedness, in each case, of that subsidiary guarantor. The subsidiary guarantees will also be effectively subordinated to any secured indebtedness of the subsidiary guarantor with respect to the assets securing that indebtedness. Absent both default and notice as specified in the Company’s Credit Facility and agreements governing the Company’s outstanding convertible notes and the Senior Subordinated Notes, there are no restrictions on the Company’s ability to obtain funds from its subsidiary guarantors by dividend or loan.

25


     The Company has not presented separate financial and narrative information for each of the subsidiary guarantors, because it believes that such financial and narrative information would not provide investors with any additional information that would be material in evaluating the sufficiency of the guarantees. Therefore, the following condensed consolidating financial information summarizes the financial position, and results of operations, and cash flows for the Company’s guarantor and non-guarantor subsidiaries.
Condensed Consolidating Statements of Operations
(Unaudited)
                     
      Guarantor  Non-guarantor       
Three Months Ended February 28, 2006 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net sales $  $128.7  $  $  $128.7 
Cost of products sold     121.8         121.8 
Selling, general and administrative  5.6   2.4         8.0 
Depreciation and amortization  0.5   6.0         6.5 
Interest expense  5.3   1.0         6.3 
Other, net  (0.6)  0.5         (0.1)
                
Loss from continuing operations before income taxes and cumulative effect of a change in accounting principle  (10.8)  (3.0)        (13.8)
Income tax (benefit) provision  (5.2)  5.8         0.6 
                
Loss from continuing operations before the cumulative effect of a change in accounting principle  (5.6)  (8.8)        (14.4)
Loss from discontinued operations  (0.8)     (0.1)     (0.9)
Cumulative effect of a change in accounting principle, net of tax  (0.7)           (0.7)
                
Loss before equity losses of subsidiaries  (7.1)  (8.8)  (0.1)     (16.0)
Equity losses of subsidiaries  (8.9)        8.9    
                
Net income (loss) $(16.0) $(8.8) $(0.1) $8.9  $(16.0)
                 
                     
      Guarantor  Non-guarantor       
Three Months Ended February 28, 2005 (in millions): Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net sales $  $139.9  $  $  $139.9 
Cost of products sold     130.3         130.3 
Selling, general and administrative  5.3   2.2         7.5 
Depreciation and amortization  0.6   6.1         6.7 
Interest expense  6.8   0.3         7.1 
Other, net  17.3   1.0         18.3 
                
Loss from continuing operations before income taxes  (30.0)           (30.0)
Income tax provision               
                
Loss from continuing operations  (30.0)           (30.0)
Loss from discontinued operations  (0.5)  (0.2)  (0.7)     (1.4)
                
Loss before equity losses of subsidiaries  (30.5)  (0.2)  (0.7)     (31.4)
Equity losses of subsidiaries  (0.9)        0.9    
                
Net income (loss) $(31.4) $(0.2) $(0.7) $0.9  $(31.4)
                

2526


Condensed Consolidating Balance Sheets
(Unaudited)
                     
      Guarantor  Non-guarantor       
February 28, 2006 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Cash and cash equivalents $56.9  $(7.0) $0.5  $  $50.4 
Accounts receivable     73.8         73.8 
Inventories     73.2         73.2 
Recoverable from the U.S. government and other third parties for environmental remediation costs     31.9         31.9 
Prepaid expenses and other  3.2   20.3         23.5 
Assets of discontinued operations  (0.2)     0.2       
                
Total current assets  59.9   192.2   0.7      252.8 
Property, plant and equipment, net  0.7   136.6         137.3 
Recoverable from the U.S. government and other third parties for environmental remediation costs     162.6         162.6 
Prepaid pension asset  109.5   113.0         222.5 
Goodwill     102.0         102.0 
Intercompany, net  (364.3)  377.3   (13.0)      
Other noncurrent assets and intangibles, net  700.3   107.5   9.8   (692.3)  125.3 
                
Total assets $506.1  $1,191.2  $(2.5) $(692.3) $1,002.5 
                
Short-term borrowings and current portion of long-term debt $1.1  $  $  $  $1.1 
Accounts payable  1.5   28.9         30.4 
Reserves for environmental remediation  4.3   54.5         58.8 
Income taxes payable  8.0   (1.6)        6.4 
Other current liabilities and postretirement medical and life benefits  30.8   126.1         156.9 
Liabilities of discontinued operations        1.8      1.8 
                
Total current liabilities  45.7   207.9   1.8      255.4 
Long-term debt, net of current portion  442.2            442.2 
Reserves for environmental remediation  7.1   195.9         203.0 
Other noncurrent liabilities  94.7   90.8         185.5 
                
Total liabilities  589.7   494.6   1.8      1,086.1 
Total shareholders’ (deficit) equity  (83.6)  696.6   (4.3)  (692.3)  (83.6)
                
Total liabilities and shareholders’ (deficit) equity $506.1  $1,191.2  $(2.5) $(692.3) $1,002.5 
                

27


                     
      Guarantor  Non-guarantor       
November 30, 2005 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Cash and cash equivalents $99.7  $(8.4) $0.4  $  $91.7 
Accounts receivable     82.1         82.1 
Inventories     57.5         57.5 
Recoverable from the U.S. government and other third parties for environmental remediation costs     24.6         24.6 
Prepaid expenses and other  3.0   21.7         24.7 
Assets of discontinued operations  (2.4)     2.4       
                
Total current assets  100.3   177.5   2.8      280.6 
Property, plant and equipment, net  0.7   139.5         140.2 
Recoverable from the U.S. government and other third parties for environmental remediation costs     171.4         171.4 
Prepaid pension asset  111.3   121.9         233.2 
Goodwill     102.0         102.0 
Intercompany, net  (386.9)  401.7   (14.8)      
Other noncurrent assets and intangibles, net  709.2   112.3   9.8   (701.3)  130.0 
                
Total assets $534.6  $1,226.3  $(2.2) $(701.3) $1,057.4 
                
Short-term borrowings and current portion of long-term debt $1.4  $  $  $  $1.4 
Accounts payable  7.1   50.0         57.1 
Reserves for environmental remediation  4.7   47.0         51.7 
Income taxes payable  13.3   (7.4)        5.9 
Other current liabilities and postretirement medical and life benefits  32.8   121.6         154.4 
Liabilities of discontinued operations        1.9      1.9 
                
Total current liabilities  59.3   211.2   1.9      272.4 
Long-term debt, net of current portion  442.5            442.5 
Reserves for environmental remediation  7.6   208.7         216.3 
Other noncurrent liabilities  97.9   101.0         198.9 
                
Total liabilities  607.3   520.9   1.9      1,130.1 
Total shareholders’ (deficit) equity  (72.7)  705.4   (4.1)  (701.3)  (72.7)
                
Total liabilities and shareholders’ (deficit) equity $534.6  $1,226.3  $(2.2) $(701.3) $1,057.4 
                

28


Condensed Consolidating Statements of IncomeCash Flows
(Unaudited)
                     
      Guarantor  Non-guarantor       
Three Months Ended August 31, 2005 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net sales $  $134  $  $  $134 
Cost of products sold     120         120 
Selling, general and administrative  4   2         6 
Depreciation and amortization     7         7 
Interest expense  5   1         6 
Other, net               
                
Income (loss) from continuing operations before income taxes  (9)  4         (5)
Income tax benefit (provision)  13   (13)         
                
Income (loss) from continuing operations  4   (9)        (5)
Loss from discontinued operations     (24)        (24)
                
Income (loss) before equity earnings  4   (33)        (29)
Equity earnings of subsidiaries  (33)        33    
                
Net income (loss) $(29) $(33) $  $33  $(29)
                
                     
      Guarantor  Non-guarantor       
Three months ended February 28, 2006 (in millions): Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net cash used in operating activities $(21.6) $(18.4) $(0.5) $  $(40.5)
Cash flows from investing activities:                    
Capital expenditures     (2.5)        (2.5)
                
Net cash used in investing activities     (2.5)        (2.5)
Cash flows from financing activities:                    
Net transfers (to) from parent  (19.9)  21.7   (1.8)      
Repayments on notes payable and long-term debt, net  (1.2)           (1.2)
Other financing activities  2.2   0.7         2.9 
                
Net cash provided by (used in) financing activities  (18.9)  22.4   (1.8)     1.7 
                
Net increase (decrease) in cash and cash equivalents  (40.5)  1.5   (2.3)     (41.3)
Cash and cash equivalents at beginning of year  97.4   (8.5)  2.8      91.7 
                
Cash and cash equivalents at end of period $56.9  $(7.0) $0.5  $  $50.4 
                
                     
      Guarantor  Non-guarantor       
Three Months Ended August 31, 2004 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net sales $  $116  $  $  $116 
Cost of products sold     114         114 
Selling, general and administrative  7   4         11 
Depreciation and amortization  2   6         8 
Interest expense  9            9 
Other, net  2   (16)        (14)
                
Income (loss) from continuing operations before income taxes  (20)  8         (12)
Income tax provision     (4)  1      (3)
                
Loss from continuing operations  (20)  4   1      (15)
Income (loss) from discontinued operations  (5)  2   (29)     (32)
                
Loss before equity earnings  (25)  6   (28)     (47)
Equity earnings of subsidiaries  (22)        22    
                
Net income (loss) $(47) $6  $(28) $22  $(47)
                
                     
      Guarantor  Non-guarantor       
Nine Months Ended August 31, 2005 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net sales $  $421  $  $  $421 
Cost of products sold     381         381 
Selling, general and administrative  16   6         22 
Depreciation and amortization  1   20         21 
Interest expense  17   2         19 
Other, net  17   3         20 
                
Income (loss) from continuing operations before income taxes  (51)  9         (42)
Income tax benefit (provision)  28   (15)        13 
                
Income (loss) from continuing operations  (23)  (6)    ��   (29)
Loss from discontinued operations  (1)  (21)  (3)     (25)
                
Income (loss) before equity earnings  (24)  (27)  (3)     (54)
Equity earnings of subsidiaries  (30)        30    
                
Net income (loss) $(54) $(27) $(3) $30  $(54)
                

26


                     
      Guarantor  Non-guarantor       
Nine Months Ended August 31, 2004 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net sales $  $350  $  $  $350 
Cost of products sold     319         319 
Selling, general and administrative  25   9         34 
Depreciation and amortization  5   20         25 
Interest expense  24   1         25 
Other, net  1   (15)        (14)
                
Income (loss) from continuing operations before income taxes  (55)  16         (39)
Income tax provision     (33)        (33)
                
Loss from continuing operations  (55)  (17)        (72)
Loss from discontinued operations  (72)  14   (248)     (306)
                
Loss before equity earnings  (127)  (3)  (248)     (378)
Equity earnings of subsidiaries  (251)        251    
                
Net income (loss) $(378) $(3) $(248) $251  $(378)
                
                     
      Guarantor  Non-guarantor       
Three months ended February 28, 2005 (in millions): Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net cash used in operating activities $(22.1) $(27.3) $(3.6) $  $(53.0)
Cash flows from investing activities:                    
Capital expenditures     (1.7)        (1.7)
Other investing activities  201.3   (7.1)        194.2 
                
Net cash provided by (used in) investing activities  201.3   (8.8)        192.5 
Cash flows from financing activities:                    
Net transfers (to) from parent  (42.5)  38.9   3.6       
Borrowings (repayments) on notes payable and long-term debt, net  (177.8)           (177.8)
Other financing activities  3.4   (1.7)        1.7 
                
Net cash provided by (used in) financing activities  (216.9)  37.2   3.6      (176.1)
                
Net increase (decrease) in cash and cash equivalents  (37.7)  1.1         (36.6)
Cash and cash equivalents at beginning of year  67.3   0.6         67.9 
                
Cash and cash equivalents at end of period $29.6  $1.7  $  $  $31.3 
                
Condensed Consolidating Balance Sheets
                     
      Guarantor  Non-guarantor       
August 31, 2005 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Cash and cash equivalents $2  $  $1  $  $3 
Accounts receivable, net  2   94         96 
Inventories, net     194         194 
Recoverable from the U.S. government and other third parties for environmental remediation costs     47         47 
Prepaid expenses and other     11         11 
Assets of discontinued operations     109   1      110 
                
Total current assets  4   455   2      461 
Property, plant and equipment, net  1   136         137 
Recoverable from the U.S. government and other third parties for environmental remediation costs     171         171 
Prepaid pension asset  115   130         245 
Goodwill     103         103 
Intercompany, net  (357)  372   (15)      
Other noncurrent assets and intangibles, net  935   106   10   (926)  125 
                
Total assets $698  $1,473  $(3) $(926) $1,242 
                
Short-term borrowings and current portion of long-term debt $2  $  $  $  $2 
Accounts payable  2   33         35 
Reserves for environmental remediation  6   58         64 
Income taxes payable  8   15         23 
Other current liabilities and other postretirement benefits other than pensions  22   126         148 
Liabilities of discontinued operations     23   3      26 
                
Total current liabilities  40   255   3      298 
Long-term debt, net of current portion  422            422 
Reserves for environmental remediation  7   213         220 
Other noncurrent liabilities  99   101         200 
                
Total liabilities  568   569   3      1,140 
Total shareholders’ equity  130   904   (6)  (926)  102 
                
Total liabilities and shareholders’ equity $698  $1,473  $(3) $(926) $1,242 
                

27


                     
      Guarantor  Non-guarantor       
November 30, 2004 (in millions) Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Cash and cash equivalents $67  $1  $  $  $68 
Restricted cash  23            23 
Accounts receivable, net  4   84         88 
Inventories, net     159         159 
Recoverable from the U.S. government and other third parties for environmental remediation costs     36         36 
Prepaid expenses and other  1   5         6 
Assets of discontinued operations     93   1      94 
                
Total current assets  95   378   1      474 
Restricted cash  178            178 
Property, plant and equipment, net  1   144         145 
Recoverable from the U.S. government and other third parties for environmental remediation costs     197         197 
Prepaid pension asset  122   156         278 
Goodwill     103         103 
Intercompany, net  (429)  444   (15)      
Other noncurrent assets and intangibles, net  937   97   10   (924)  120 
                
Total assets $904  $1,519  $(4) $(924) $1,495 
                
Short-term borrowings and current portion of long-term debt $23  $  $  $  $23 
Accounts payable  6   49         55 
Reserves for environmental remediation  7   44         51 
Income taxes payable  23   12         35 
Other current liabilities and other postretirement benefits other than pensions  35   121         156 
Liabilities of discontinued operations     11   7      18 
                
Total current liabilities  94   237   7      338 
Long-term debt, net of current portion  554            554 
Reserves for environmental remediation  9   244         253 
Other noncurrent liabilities  106   103         209 
                
Total liabilities  763   584   7      1,354 
Total shareholders’ equity  141   935   (11)  (924)  141 
                
Total liabilities and shareholders’ equity $904  $1,519  $(4) $(924) $1,495 
                
Condensed Consolidating Statements of Cash Flows
                     
      Guarantor  Non-guarantor       
Nine months ended August 31, 2005 (in millions): Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net cash used in operating activities $(30) $(29) $(6) $  $(65)
Cash flows from investing activities:                    
Capital expenditures     (9)         (9)
Other investing activities  201   (28)         173 
                
Net cash provided by (used in) investing activities  201   (37)        164 
Cash flows from financing activities:                    
Net transfers (to) from parent  (78)  71   7       
Borrowings (repayments) on notes payable and long-term debt, net  (168)           (168)
Other financing activities  10   (6)        4 
                
Net cash provided by (used in) financing activities  (236)  65   7      (164)
                
Net increase (decrease) in cash and cash equivalents  (65)  (1)  1      (65)
Cash and cash equivalents at beginning of year  67   1         68 
                
Cash and cash equivalents at end of period $2  $  $1  $  $3 
                

28


                     
      Guarantor  Non-guarantor       
Nine months ended August 31, 2004 (in millions): Parent  Subsidiaries  Subsidiaries  Eliminations  Consolidated 
Net cash used in operating activities $(42) $(26) $(8) $  $(76)
Cash flows from investing activities:                    
Capital expenditures     (11)        (11)
Proceeds from business disposition  140            140 
Other investing activities  (79)  (4)  (24)     (107)
                
Net cash provided by (used in) investing activities  61   (15)  (24)     22 
Cash flows from financing activities:                    
Net transfers (to) from parent  (74)  46   28       
Borrowings (repayments) on notes payable and long-term debt, net  59      (36)     23 
Other financing activities  13   (5)  (6)     2 
                
Net cash provided by (used in) financing activities  (2)  41   (14)     25 
                
Effect of exchange rate fluctuations on cash and cash equivalents        (4)     (4)
Net increase (decrease) in cash and cash equivalents  17      (50)     (33)
Cash and cash equivalents at beginning of year  9   3   52      64 
                
Cash and cash equivalents at end of period $26  $3  $2  $  $31 
                
17. New Accounting Pronouncements18. Subsequent Events
     In December 2004,During the FASB issued Statement 123(R),Share-Based Payment, which requires all companies to measure compensation cost for all share-based payments (including employee stock options) at fair value. In April 2005, the SEC issued a release which amends the compliance dates for Statement 123(R). The Company will now be required to adopt the new accounting provisions beginning in the first quarter of fiscal 2006. The Company could adopt the new standard in one of two ways — the modified prospective transition method or the modified retrospective transition method. The Company will adopt Statement 123(R) in the firstsecond quarter of fiscal 2006, and does not anticipate that the adoptionCompany will be issuing $35 million — $42 million of additional letters of credit related to environmental obligations, of which $18 million — $25 million will be issued under the Statement 123(R) will have a significant effect on earnings or the financial position of the Company.Revolver, reducing available borrowing capacity.

29


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
     Unless otherwise indicated or required by the context, as used in this Quarterly Report on Form 10-Q, the terms “we,” “our” and “us” refer to GenCorp Inc. and all of its subsidiaries that are consolidated in conformity with accounting principles generally accepted in the United States.States of America.
     The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In addition, our operating results for interim periods may not be indicative of the results of operations for a full year. This section contains a number of forward–looking statements, all of which are based on current expectations and are subject to risks and uncertainties including those described in this Quarterly Report under the heading “Forward-Looking Statements.” Actual results may differ materially. This section should be read in conjunction with our Annual Report on Form 10-K for the year ended November 30, 2004,2005, and periodic reports subsequently filed with the U.S. Securities and Exchange Commission (SEC).
Overview
     We are a technology-based manufacturer operating primarily inof aerospace and defense products and systems with a real estate business segment that includes activities related to the United States.entitlement, sale, and leasing of our excess real estate assets. Our continuing operations are organized into two operating segments:
Aerospace and Defense and Real Estate. The Aerospace and Defense segment includes the operations of Aerojet-General Corporation, or Aerojet, which develops and manufactures propulsion systems for spacedefense and defensespace applications, armament systems for precision tactical weapon systems and munitions applications,applications. We are one of the largest providers of propulsion systems in the United States and advanced airframe structures.the only company that provides both Solid and Liquid propellant based systems. Primary customers served include major prime contractors to the U.S.United States (U.S.) government, the DoDDepartment of Defense (DoD), and NASA. The the National Aeronautics and Space Administration (NASA).
Real Estate segment includes activities related to the development,re-zoning, entitlement, sale, and leasing of our real estate assets. Through our Aerojet subsidiary, we own approximately 12,600 acres of land adjacent to U.S. Highway 50 between Rancho Cordova and Folsom, California just east of Sacramento (Sacramento Land). We are currently in the process of seeking zoning changes and other governmental approvals on a portion of the Sacramento Land to optimize its value. We have filed applications with and submitted information to governmental and regulatory authorities for approvals necessary to re-zone over 6,400 acres of the Sacramento Land.
     DuringOn November 30, 2005, the second quarter of fiscal 2004, we announced plans to sell our GDX business, which developed and manufactured vehicle sealing systems for automotive original equipment manufacturers. This decision was a result of declining volumes and continued challenges in this market environment including adverse customer pricing pressures, increased material costs, high development and start-up costs and increased working capital requirements. In accordance with our plan to sell the GDX business, we classified our GDX business as a discontinued operation during the second quarter of fiscal 2004. During the third quarter of fiscal 2004, weCompany completed the sale of GDX to Cerberus Capital Management, L.P. for $147 million, subject to adjustment, of which $140 million had been received as of August 31, 2005.
     On October 15, 2004, we announced our strategic decision to sell ourits Fine Chemicals business, which through Aerojet Fine Chemicals, is a custom manufacturer of active pharmaceutical ingredientsclassified as discontinued operations in these Unaudited Condensed Consolidated Financial Statements and registered intermediates for pharmaceutical and biotechnology companies. This plan was a result of management’s decision to focus our capital and resources on our Aerospace and Defense and Real Estate businesses. . In July 2005, we announced our plan to sell the Fine Chemicals business to American Pacific Corporation for $119 million, consisting of $100 million of cash, seller note of $19 million, and the assumption by the buyer of certain liabilities. We have recently agreed to amend the purchase agreement to modify the sale price and payment terms related to the Fine Chemicals sale. The revised purchase price consists of $89 million of cash payable at closing, seller note of $25 million delivered at closing, a contingent payment of up to $5 million if Fine Chemicals achieves specified earning targets in the twelve month period ending September 30, 2006, and the assumption by the buyer of certain liabilities. We have recorded a loss of $28 million in the third quarter based on the difference between current estimated cash proceeds to be received on disposition less the carrying value of net assets being sold and related transaction selling costs. The loss is reflected in Discontinued Operations. Income will be recorded in the future on the seller note of $25 million and any contingent payment when realized. We continue to expect the transaction to close in October 2005. See additional discussion in Note 13 in Notes to Unaudited Condensed Consolidated Financial Statements. For all periods presented, we haveIn addition, the assets and liabilities remaining related to the GDX operations after the sale to Cerberus Capital Management, L.P. on August 31, 2004 are classified the results of operations of GDX and Fine Chemicals as discontinued operations in these Unaudited Condensed Consolidated Financial Statements and Notes to Unaudited Condensed Consolidated Financial Statements.
     In March 2005, the Consolidated StatementsFinancial Accounting Standards Board (FASB) issued Interpretation 47(FIN 47),Accounting for Conditional Asset Retirement Obligations, an interpretation of Income. The assetsFASB Statement No. 143,Accounting for Asset Retirement Obligations. FIN 47 requires an entity to recognize a liability for the fair value of a conditional asset retirement obligation when incurred if the liability’s fair value can be reasonably estimated. This interpretation is effective for fiscal years ending after December 15, 2005. We are currently evaluating the effect that the adoption of FIN 47 will have on our financial position and liabilitiesresults of Fine Chemicals have been classified as Assets of Discontinued Operations and Liabilities of Discontinued Operationsoperations which we will adopt in the Consolidated Balance Sheetsfourth quarter of fiscal 2006.
Business Outlook
Aerospace and Defense—Aerojet received a number of contract awards in the first quarter of fiscal 2006, contributing to backlog growth. This recent success in winning new programs, as well as growth in many of August 31, 2005its existing programs, will offset much of the decline in Atlas V and November 30, 2004.Titan sales from fiscal 2005.
Real Estate— We are actively working with the governmental authorities to affect entitlement changes and to lift environmental restrictions for approximately 6,400 acres of the Sacramento Land as soon as practicable. In conjunction with these efforts, we will continue to explore real estate structures (or transactions) that may enhance the value of our real estate assets, including outright sales, and/or joint ventures with real estate developers, residential builders or other third parties.

30


Results of Operations
Net Sales:
                                 
  Three months ended          Nine months ended        
  August 31,  August 31,      Percentage  August 31,  August 31,      Percentage 
  2005  2004  Change*  Change  2005  2004  Change*  Change 
Net Sales $134  $116  $18   16% $421  $350  $71   20%
                 
  Three months ended        
  February 28,  February 28,      Percentage 
  2006  2005  Change*  Change 
Net Sales $128.7  $139.9  $(11.2)  (8)%
*Primary reason for change.The decrease in sales is primarily the result of the completion of the Titan program and lower sales recognized on the Standard Missile, Patriot Advanced Capability-3, and Javelin programs. These decreases were partially offset by increased deliveries to Boeing on the F-22 program and non-government sales.
     During the first quarter of fiscal 2006, Lockheed Martin and Raytheon accounted for 39% and 17%, respectively, of net sales. During the first quarter of fiscal 2005, Lockheed Martin and Raytheon accounted for 37% and 19%, respectively, of net sales. Sales in the first quarter of fiscal 2006 and fiscal 2005 directly and indirectly to the U.S. government and its agencies, including sales to our significant customers discussed above, totaled 75% and 86%, respectively, of net sales.
Cost of Products Sold:
             
  Three months ended    
  February 28,  February 28,    
  2006  2005  Change* 
Costs of products sold: $121.8  $130.3  $(8.5)
Percentage of net sales  95%  93%    
 
* Primary reason for change.The increase in cost of sales foras a percentage of net sales is primarily the result of changes in product mix that lowered margins during the first nine monthsquarter of fiscal 2005 is primarily due to the following programs: Terminal High-Altitude Area Defense (THAAD), Standard Missile, and Atlas V.2006.
     During the three months ended August 31, 2005, Lockheed MartinSelling, General and Raytheon accounted for 34% and 16%, respectively, of net sales. During the nine months ended August 31, 2005, Lockheed Martin and Raytheon accounted for 35% and 18%, respectively, of net sales. During the three months ended August 31, 2004, Lockheed Martin, Raytheon, and Boeing accounted for 35%, 17%, and 10%, respectively, of net sales. During the nine months ended August 31, 2004, Lockheed Martin, Raytheon, and Boeing accounted for 31%, 16%, and 11%, respectively, of net sales. Sales during the three and nine months ended August 31, 2005, directly and indirectly to the U.S. government and its agencies, including sales to our significant customers discussed above, totaled $111 million and $351 million, respectively. Sales during the three and nine months ended August 31, 2004 directly and indirectly to the U.S. government and its agencies, including sales to our significant customers discussed above, totaled $99 million and $299 million, respectively.
     Please refer to the “Operating Segment Information” section below for further discussions with respect to net sales for each of our operating segments.
Cost of Products Sold:Administrative:
                                    
 Three months ended Nine months ended    Three months ended   
 August 31, August 31, August 31, August 31,    February 28, February 28,   
 2005 2004 Change* 2005 2004 Change*  2006 2005 Change* 
Costs of products sold: $120 $114 $6 $381 $319 $62 
Selling, General and Administrative: $8.0 $7.5 $0.5 
Percentage of net sales  90%  98%  90%  91%   6%  5% 
 
* Primary reason for change.The change inincrease is primarily the result of costs of products sold as a percentage of net sales was due to the following: (i) $16 million write-down of inventory associated with the Atlas V programincurred in the thirdfirst quarter of fiscal 2004; (ii) increase in net periodic expense for pension and other postretirement benefits of $2 million and $5 million in the three and nine months of fiscal 2005, respectively; and (iii) changes in the current year product mix which resulted in lower margins during fiscal 2005.
Selling, General and Administrative (SG&A):
                         
  Three months ended      Nine months ended    
  August 31,  August 31,      August 31,  August 31,    
  2005  2004  Change*  2005  2004  Change* 
Selling, General and Administrative: $6  $11  $(5) $22  $34  $(12)
Percentage of net sales  4%  9%      5%  10%    
*Primary reason for change.The decrease in SG&A costs was primarily due2006 related to higher expenses related to the following: (i) lower corporate costs as a result of personnel reductions and resource redeployment to Aerojet to adjust for the reduction in operations as a resultannual election of the divestureBoard of GDX in August 2004; and (ii) decrease in net periodic expense for pension and other postretirement benefits. The cost reductions were offset by non-cash stock compensation expense of $3 million for the nine months ended August 31, 2005.Directors.

31


Depreciation and Amortization:
                                    
 Three months ended Nine months ended    Three months ended   
 August 31, August 31, August 31, August 31,    February 28, February 28,   
 2005 2004 Change* 2005 2004 Change*  2006 2005 Change* 
Depreciation and amortization: $7 $8 $(1) $21 $25 $(4) $6.5 $6.7 $(0.2)
Percentage of net sales  5%  7%  5%  7%   5%  5% 
 
* Primary reason for change.The decrease is primarily the result of lower amortization of deferred financing costs as a result of the termination of the Restated Credit Facility, the redemption of $52$52.5 million of principal of the 9 ½%1/2% Notes and the repayment of $60$59.9 million of principal of the 5 ¾%3/4% Notes during the first quarter ofin early fiscal 2005.

31


Interest Expense:
                         
  Three months ended      Nine months ended    
  August 31,  August 31,      August 31,  August 31,    
  2005  2004  Change*  2005  2004  Change* 
Interest expense: $6  $9  $(3) $19  $25  $(6)
             
  Three months ended    
  February 28,  February 28,    
  2006  2005  Change* 
Interest expense: $6.3  $7.1  $(0.8)
 
* Primary reason for change.The decrease is the result ofdue to lower average debt balances and interest rates as a result of the sale of the GDX Automotive business in August 2004 and our recent recapitalization transactions, initiated in November 2004 and completed in February 2005, which increased shareholders’ equity and lowered debt and future interest costs.
Other income, net:
                         
  Three months ended      Nine months ended    
  August 31,  August 31,      August 31,  August 31,    
  2005  2004  Change*  2005  2004  Change* 
Other (income) expense, net: $  $(14) $14  $  $(14) $14 
*Primary reason for change.During the third quarter of fiscal 2004, we reviewed our environmental reserve liability and associated cost recovery calculations, including assumptions related to the anticipated sale of our Fine Chemicals operating segment. In conjunction with the review coupled with prospective changes in the allocation methodology, we recorded $17 million of other income. The $17 million of other income recorded in the third quarter of fiscal 2004 was offset by a $2 million environmental remediation charge related to a former operating site.rates.
Unusual Items, Net:Items:
                         
  Three months ended      Nine months ended    
  August 31,  August 31,      August 31,  August 31,    
  2005  2004  Change*  2005  2004  Change* 
Unusual items, net: $  $  $  $20  $  $20 
             
  Three months ended    
  February 28,  February 28,    
  2006  2005  Change* 
Unusual items: $  $18.1  $(18.1)
 
* Primary reason for change.In the first quarter of fiscal 2005, we recorded a charge of $18$18.1 million as a result of the termination of the Restated Credit Facility, the redemption of $52$52.5 million of principal of the 9 ½%1/2% Notes, and the repayment of $60$59.9 million of principal of the 5 ¾%3/4% Notes. In the second quarter of fiscal 2005, we recorded a charge of $2 million related to an estimated legal settlement of the San Gabriel Valley and Chino Hills toxic tort cases.
Income Tax Benefit (Provision):Provision:
                         
  Three months ended      Nine months ended    
  August 31,  August 31,      August 31,  August 31,    
  2005  2004  Change*  2005  2004  Change* 
Income tax benefit(provision): $  $(3) $3  $13  $(33) $46 
             
  Three months ended    
  February 28,  February 28,    
  2006  2005  Change* 
Income tax provision: $0.6  $  $0.6 
 
* Primary reason for change.changeDuring. The income tax provision in the first nine monthsquarter of fiscal 2006 is primarily the result of establishing a valuation allowance against the current quarter’s alternative minimum tax credit carryforward, the adoption of FAS 123(R) and, similar to the first quarter of fiscal 2005, we recordeddid not record an income tax benefit of $13 million primarily for tax refund claims related to a ten-year carryback of Net Operating Losses. The benefit was recorded as a result of guidance recently issued by the Internal Revenue Service related to the calculation of the ten-year carryback claims. Conversely, in the first nine months of fiscal 2004,quarterly loss. We did not record an income tax provision was recorded to reflectbenefit for the write-offfirst quarter of the net deferred tax assetfiscal 2005 due to the uncertainty of realizing the deferred tax benefit of the currentquarterly loss, given recent historical losses.

32


Discontinued Operations:
     During the second quarter of fiscal 2004, the GDX business net assets were adjusted to management’s estimate of proceeds to be received on disposition less costs to sell. During the third quarter of fiscal 2004, we signed a definitive agreement to sell GDX, including substantially all of the assets of GenCorp Inc. that were used in the GDX business and substantially all of GenCorp Inc.’s worldwide subsidiaries that were engaged in the GDX business, to Cerberus for $147 million, subject to adjustment, of which $140 million was received as of August 31, 2005. We closed the transaction on August 31, 2004. The loss on the sale of the GDX business during fiscal 2004 was $279 million.
     During the third quarter of fiscal 2004, we classified the Fine Chemicals business as a discontinued operation as a result of our plans to sell the business. This plan was a result of management’s decision to focus our capital and resources on our Aerospace and Defense and Real Estate operating segments. DuringOn November 30, 2005, we completed the third quartersale of fiscal 2005,the Fine Chemicals to American Pacific Corporation (AMPAC) for $114.0 million, subject to adjustment, consisting of $88.5 million of cash, unsecured subordinated seller note of $25.5 million, and the assumption by the buyer of certain liabilities. Additionally, AMPAC will be required to pay us up to $5.0 million based on the Fine Chemical business achieving specified earnings targets in the twelve month period ending September 30, 2006. Income will be recorded in the future on the seller note of $26 million and any contingent payment when realized. The loss on the sale of the Fine Chemicals business net assets were adjusted to management’s estimated proceeds to be received on disposition less costs to sell. The resultingduring fiscal 2005 was $28.7 million. An additional loss recognized on this adjustment of $28$0.1 million has beenwas recorded as a component of Loss from Discontinued Operations in the thirdfirst quarter of fiscal 2005.2006 to reflect the net assets of the Fine Chemicals business and management’s estimate of the proceeds from the sale.
     In November 2003, we announced the closing of a GDX manufacturing facility in Chartres, France. The decision resulted primarily from declining sales volumes with French automobile manufacturers. In June 2004, we completed the legal process for closing the facility and establishing a social plan. In fiscal 2004,2005, an expense of approximately $14$1.0 million related to employee social costs was recorded in accordance with SFAS No. 146,Accounting for Costs Associated with Exit ofor Disposal Activities.ActivitiesAn expense of $1 million was recorded during the first nine months of fiscal 2005 primarily related to employee social costs that became estimable in the first nine months of fiscal 2005 and is included as a component of discontinued operations.. We have not yet recorded expenses associated with certain social benefits due to the uncertainty of the benefit amount. These additional social costs are expected tomay result in an additional pre-tax expense of up to $2$2.0 million and are anticipated to be incurred over the next 12 months to 15 months.

32


     Summarized financial information for the GDX and Fine Chemicalsdiscontinued operations is set forth below:
        
                 Three months ended 
 Three months ended August 31, Nine months ended August 31,  February 28, February 28, 
 2005 2004 2005 2004  2006 2005 
 (in millions)  (in millions) 
Net sales $18 $191 $41 $605  $ $10.0 
Loss before income taxes  (24)  (33)  (25)  (308)  (0.9)  (1.4)
Income tax benefit  1  2 
Net loss from discontinued operations  (24)  (32)  (25)  (306)
Income tax provision   
Loss from discontinued operations, net of income taxes  (0.9)  (1.4)
Cumulative Effect of a Change in Accounting Principle:
     As of December 1, 2005, we adopted Statement of Financial Accounting Standards (SFAS) No.123(R),Share-Based Payment,(SFAS 123(R)), which requires companies to recognize in the statement of operations the grant-date fair value of stock awards issued to employees and directors. We adopted SFAS 123(R) using the modified prospective transition method. In accordance with the modified prospective transition method, our Consolidated Financial Statements for prior periods have not been restated to reflect the impact of SFAS 123(R). As a result of applying SFAS 123(R), the loss from continuing operations before cumulative effect of a change in accounting principle for the first quarter of fiscal 2006 was increased by $0.4 million. In addition, we recognized an increase to our net loss of $0.7 million related to the cumulative effect of a change in accounting principle as of December 1, 2005 (see Note 3 of the Unaudited Condensed Consolidated Financial Statements).
Operating Segment Information:
     Our continuing operations are organized into two segments based on different products and customer bases: Aerospace and Defense and Real Estate. We evaluate our operating segments based on several factors, of which the primary financial measure is segment performance. Segment performance, which is a non-GAAP financial measure, represents net sales from continuing operations less applicable costs, expenses and provisions for restructuring and unusual items relating to operations. Segment performance excludes corporate income and expenses, commercial legacy income or expenses, provisions for unusual items not related to the operations, interest expense, and income taxes,taxes. We believe that segment performance provides information useful to investors in understanding our underlying operational performance. Specifically, we believe the exclusion of the items listed above permits an evaluation and discontinued operations.a comparison of results for ongoing business operations, and it is on this basis that management internally assesses operational performance.
Aerospace and Defense Segment
                                                
 Three months ended Nine months ended    Three months ended   
 August 31, August 31, Percentage August 31, August 31, Percentage  February 28, February 28, Percentage 
 2005 2004 Change* Change 2005 2004 Change* Change  2006 2005 Change* Change 
Net Sales $132 $116 $16  14% $416 $354 $62  18% $127.2 $138.2 $(11.0)  (8)%
Segment Performance 7 11  (4)  (36)% 15 23  (8)  (35)%
Segment performance – Income (Loss) $(0.5) $1.6 $(2.1)  (131)%
 
* Primary reason for change.Sales improvements duringThe decrease in sales is primarily the third quarterresult of fiscal 2005 as compared to the prior year quarter include increases incompletion of the following programs:Titan program and lower sales recognized on the Standard Missile, Atlas V,Patriot Advanced Capability-3, and Terminal High-Altitude Area Defense (THAAD).Javelin programs. These decreases were partially offset by increased deliveries to Boeing on the F-22 program and non-government sales.
     ThirdSegment performance was a loss of $0.5 million in the first quarter segment performance inof fiscal 2005 was $7 million2006 compared to $11income of $1.6 million in the first quarter of fiscal 2004.2005. Excluding the impact of employee retirement benefit plan expense and unusual items, segment performance was $16income of $8.2 million (12.1% of sales) in the thirdfirst quarter of fiscal 2005,2006 compared to $18income of $10.2 million (15.5% of sales) in the thirdfirst quarter of fiscal 2004. For the first nine months of fiscal 2005,2005. Decreased segment performance was $15 million comparedprimarily due to $23 millionthe overall lower sales volume, and in fiscal 2004. Excludingparticular, the effect of employee retirement benefit plan expense and unusual items, segment performance was $43 million (10.3%the completion of sales) in fiscal 2005 compared to $44

33


million (12.4% of sales) in fiscal 2004. Significant factors impacting the change in segment performance compared to prior year were: (i) $16 million write-down of inventory associated with the Atlas V program in the third quarter of 2004; (ii) environmental reserve and recovery adjustments that resulted inlong running fixed price Titan production contract which generated a $17 million favorable impact to 2004 segment performance; and (iii) changes in product mix that resulted in lower margins during 2005.high margin.
     As of August 31, 2005,February 28, 2006, Aerojet’s contract backlog was $936$741.6 million as compared to $879$695.8 million as of November 30, 2004.2005. Funded backlog, which includes only the amount of those contracts for which money has been directly authorized by the U.S. Congress, or for which

33


a firm purchase order has been received by a commercial customer, totaled approximately $562was $549.2 million as of August 31, 2005at February 28, 2006 compared to $538$498.1 million as of November 30, 2004.2005.
Real Estate Segment
                                 
  Three months ended          Nine months ended        
  August 31,  August 31,      Percentage  August 31,  August 31,      Percentage 
  2005  2004  Change*  Change  2005  2004  Change*  Change 
Net Sales $2  $2  $     $5  $4  $1   25%
Segment Performance  1   1         3   3      %
     Our actions related to the entitlement process for Rio Del Oro, Glenborough, and Westborough continued during the first quarter of fiscal 2006. The actions covered such items as environmental remediation, land planning, traffic, wetlands, endangered species mitigation, and water supplies.
                 
  Three months ended        
  February 28,  February 28,      Percentage 
  2006  2005  Change*  Change 
Net Sales $1.5  $1.7  $(0.2)  (12)%
Segment performance $0.8  $1.0  $(0.2)  (20)%
 
* Primary reason for change.There were no real estate asset sales during the first nine monthsquarter of fiscal 2005 and2006 or fiscal 2004.2005. Sales for the first nine monthsquarter of fiscal 20052006 and fiscal 20042005 consist of rental property operations.
Other Information
     Our policy is to conduct our businesses with due regard for the preservation and protection of the environment. We devote a significant amount of resources and management attention to environmental matters and actively manage our ongoing processes to comply with environmental laws and regulations. We are involved in the remediation of environmental conditions that resulted from generally accepted manufacturing and disposal practices in the 1950s and 1960s followed at certain plants. In addition, we have been designated a PRP with other companies at third party sites undergoing investigation and remediation.
     Estimating environmental remediation costs is difficult due to the significant uncertainties inherent in these activities, including the extent of the remediation required, changing governmental regulations and legal standards regarding liability, evolving technologies and the long periods of time over which most remediation efforts take place. In accordance with the American Institute of Certified Public Accountants’ Statement of Position 96-1 (SOP 96-1),Environmental Remediation Liabilitiesand Staff Accounting Bulletin No. 92 (SAB92),Accounting and Disclosure Relating to Loss Contingencies,we:
accrue for costs associated with the remediation of environmental pollution when it becomes probable that a liability has been incurred and when our proportionate share of the costs can be reasonably estimated. In some cases, only a range of reasonably possible costs can be estimated. In establishing our reserves, the most probable estimate is used when determinable and the minimum estimate is used when no single amount is more probable; and
record related estimated recoveries when such recoveries are deemed probable
Key Accounting Policies and Estimates
     Our financial statements are prepared in accordance with accounting principles generally accepted in the United States that offeroffers acceptable alternative methods for accounting for certain items affecting our financial results, such as determining inventory cost, depreciating long-lived assets and recognizing revenues.
     The preparation of financial statements requires the use of estimates, assumptions, judgments and interpretations that can affect the reported amounts of assets, liabilities, revenues and expenses, the disclosure of contingent assets and liabilities and other supplemental disclosures. The development of accounting estimates is the responsibility of our management. Management discusses those areas that require significant judgments with the audit committee of our board of directors. The audit committee has reviewed all financial disclosures in our filings with the SEC. Although we believe that the positions we have taken with regard to uncertainties are reasonable, others might reach different conclusions and our positions can change over time as more information becomes available. If an accounting estimate changes, its effects are accounted for prospectively.

34


     The areas most affected by our accounting policies and estimates are revenue recognition for long-term contracts, goodwill and other long-lived assets, employee pension and postretirement benefit obligations, litigation, environmental remediation costs and recoveries, and income taxes. Except for income taxes, which are not allocated to our operating segments, these areas affect the financial results of our business segment.segments.
     These areas are discussedA detailed description of our significant accounting policies can be found in more detail in our most recent Annual Report on Form 10-K for the fiscal year ended November 30, 2004. There have been no significant changes2005. As of December 1, 2005, the Company began recognizing and measuring its stock-based compensation in our key accounting policies duringaccordance with SFAS 123(R). Prior to adoption of SFAS 123(R), the first nine months of fiscal 2005.Company recognized and measured its share-based compensation in accordance with Accounting Principles Board Opinion No 25,Accounting for Stock Issued to Employees, and related interpretations.
Arrangements with Off-Balance Sheet Risk
     As of August 31, 2005,February 28, 2006, obligations required to be disclosed in accordance with Financial Accounting Standards Board (FASB)FASB Interpretation No. 45 (FIN 45),Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of the Indebtedness of Othersconsisted of:
$57 million in outstanding commercial letters of credit expiring in fiscal 2005 and fiscal 2006 securing obligations for environmental remediation, insurance coverage and litigation.
     — $27.5 million in outstanding commercial letters of credit expiring in 2007 and securing obligations for environmental remediation and insurance coverage.
Up to $120     — Up to $120.0 million aggregate in guarantees by GenCorp Inc. of Aerojet’s obligations to government agencies for environmental remediation activities.

34


Guarantees, jointly and severally, by our material domestic subsidiaries of our obligations under our senior credit facilities and our 9 1/2%
     — Guarantees, jointly and severally, by the Company’s material domestic subsidiaries of its obligations under its senior credit facilities and its 91/2% Notes.
New Accounting Pronouncements
     In December 2004,addition to the FASB issued Statement 123(R),Share-Based Payment,items discussed above, we will from time to time enter into certain types of contracts that require us to indemnify parties against potential third-party and other claims. These contracts primarily relate to: (i) divestiture agreements, under which requires all companieswe may provide customary indemnifications to measure compensation costpurchasers of our businesses or assets including, for all share-based payments (including employee stock options) at fair value. In April 2005,example, claims arising from the SEC issued a releaseoperation of the businesses prior to disposition, liability to investigate and remediate environmental contamination existing prior to disposition; (ii) certain real estate leases, under which amends the compliance dates for Statement 123(R). We will nowwe may be required to adoptindemnify property owners for other claims arising from the new accounting provisions beginning inuse of the applicable premises; and, (iii) certain agreements with officers and directors, under which we may be required to indemnify such persons for liabilities arising out of their employment relationship.
     The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, we have not been obligated to make significant payments for these obligations, and no liabilities have been recorded for these obligations on our balance sheet as of February 28, 2006 or November 30, 2005.
Liquidity and Capital Resources
Liquidity Requirements
     Short-term liquidity requirements for the first quarter of fiscal 2006. We could adopt2006 consisted of normal recurring operating expenses and working capital requirements; costs associated with legacy business matters, including costs related to our retirement benefit plans; capital expenditures; debt service requirements; and payment of liabilities accrued as of November 30, 2005 related to the new standard in one of two ways — the modified prospective transition method or using the modified retrospective transition method. We do not anticipate that the adoptionsale of the Statement 123(R) will have a significant effect on our earnings or financial position.

35


Liquidity and Capital ResourcesFine Chemicals business in the fourth quarter of fiscal 2005.
     Cash and cash equivalents decreased by $65$41.3 million during the first nine monthsquarter of fiscal 2005.2006. The change in cash and cash equivalents is as follows:
                
 Nine Months Ended  Three Months Ended 
 August 31, August 31,  February 28, February 28, 
 2005 2004  2006 2005 
 (in millions)  (in millions) 
Net Cash Used in Operating Activities:
  
Continuing operations $(59) $(44) $(33.3) $(52.1)
Discontinued operations  (6)  (32)  (7.2)  (0.9)
          
Total  (65)  (76)  (40.5)  (53.0)
Net Cash Provided by Investing Activities:
 
Net Cash Provided by (Used in) Investing Activities:
 
Continuing operations 192 59   (2.5) 199.6 
Discontinued operations  (28)  (37)   (7.1)
          
Total 164 22   (2.5) 192.5 
Net Cash (Used in) Provided by Financing Activities:
  (164) 25 
Effect of exchange rate fluctuations on cash and cash equivalents   (4)
Net Cash Provided by (Used in) Financing Activities:
 1.7  (176.1)
          
Net Decrease in Cash and Cash Equivalents $(65) $(33) $(41.3) $(36.6)
          
Net Cash Used In Operating Activities
Continuing Operations
     NetFirst Quarter Fiscal 2006 versus First Quarter Fiscal 2005— Continuing operations used cash used in continuing operations for the first nine months of fiscal 2005 was $59 million compared with $64$33.3 million in the first nine monthsquarter of fiscal 2004 excluding2006 compared to cash usage of $52.1 million in the one-time repaymentfirst quarter of a $20fiscal 2005. The year over year change consists of: (i)reduced cash usage in the Aerospace and Defense segment primarily reflecting the renegotiation of the Atlas V contract with Lockheed Martin Corporation in December 2005; (ii) reduction in cash paid for interest; and (iii) reduction in cash paid for corporate expenses.
Discontinued Operations
     Discontinued operations used cash of $7.2 million note receivable in our real estate segment. Both periods reflect working capital requirements duethe first quarter of fiscal 2006 primarily for payment of liabilities accrued as of November 30, 2005 related to the timingsale of receivables and payables, Atlas V inventory increases, andthe Fine Chemicals business compared to $0.9 million in the first quarter of fiscal 2005, primarily reflecting operating cash interest expense. Fiscal 2005 working capital is also impactedusage by the growth in Aerojet’s business volume.Fine Chemicals business.

35


Net Cash Provided By (Used In) Investing Activities Continuing Operations
   Cash provided by investing activities for continuingContinuing Operations
First Quarter Fiscal 2006— Continuing operations was $192 million and $59used cash of $2.5 million for the first nine months of fiscal 2005 and fiscal 2004, respectively. Investing activities for continuing operations in the first nine months of fiscal 2005 reflects $201 million of restricted cash which was used to repay debt as discussed below in financing activities. Restricted cash represented proceeds from the GDX Automotive sale completed in August 2004 and the equity offering completed in November 2004. Investing activities for continuing operations in the first nine months of fiscal 2004 reflects $140 million received from the sale of the GDX business, less $70 million of the proceeds held as restricted cash.
     Investing activities for continuing operations included capital expenditures of $9 million and $11 million for the first nine months of fiscal 2005 and fiscal 2004, respectively.expenditures. Capital expenditures directly support our contract and customer requirements and are primarily made for asset replacement, capacity expansion, development of new projects, cost reduction initiatives, and safety and productivity improvements.
First Quarter Fiscal 2005— Continuing operations provided cash of $199.6 million consisting of $201.3 million of restricted cash which was used to repay debt as discussed below in financing activities; offset by $1.7 million in capital expenditures.
Restricted Cash— As of November 30, 2004, we designated $201.3 million as restricted cash, consisting of a portion of the proceeds from the GDX Automotive sale and the proceeds from the Equity Offering completed in fiscal 2004.
Discontinued Operations
     Discontinued operations used cash of $7.1 million in the first quarter of fiscal 2005 for capital expenditures in the Fine Chemicals business.
Net Cash Provided By (Used In) Provided By Financing Activities
     Net cash used in financingFirst Quarter Fiscal 2006— Cash of $1.7 million was generated from other equity transactions, primarily employee stock options, offset by activities for the first nine months of fiscal 2005 was $164 million and net cash provided by financing activities for the first nine months of fiscal 2004 was $25 million. Cash flow related to financing activities in both periods relate primarily to activities involving our borrowings net ofincluding debt repayments.
     The first nine monthsFirst Quarter Fiscal 2005— Cash used of fiscal 2005$176.1 million reflects the completion of our capital restructuringrecapitalization initiated in November 2004 with net cash proceeds of $64 million from the issuance of our additional 2 ¼% Debentures, net cash proceeds of $21 million from the issuance of a Term Loan, cash used to repay $2632004. We redeemed $263.2 million of outstanding debt including $10redemption costs, offset by $66.4 million from issuance of premiumadditional 21/4% Debentures, and transaction costs, $10$25.0 million from issuance of Term Loans under our Senior Credit Facility. In addition, we incurred $6.0 million in revolver borrowings,debt issuance costs and $4received $1.7 million in other equity transactions. The following transactions, were completed in the first nine months of fiscal 2005:primarily employee stock options.
In December 2004, an initial purchaser exercised its option to purchase additional 2 ¼% Debentures totaling $66 million aggregate principal amount. Cash proceeds, net of underwriting discountsBorrowing Activity, Debt and transaction costs were $64 million and were used to repurchase $60 million of the 5 ¾% Notes, plus premium, accrued interest and transaction costs.

36


In December 2004, we entered into a new $180 million credit facility (New Credit Facility) that replaced the previous credit facility (Restated Credit Facility). (See Note 8 to the Unaudited Condensed Consolidated Financial Statements).Facility:
     The outstanding term loans under the Restated Credit Facility totaling $141 million, plus accrueddebt as of February 28, 2006 had effective interest were repaid in full using restricted cashrates ranging from the proceeds of the GDX Automotive sale completed in August 2004 and the equity offering completed in November 2004. Cash proceeds from the $25 million term loan under the New Credit Facility, net of underwriting fees and expenses associated2.25% to 9.50%, with the New Credit Facility were $21 million and will be used for general corporate purposes.
maturities as follows:
In February 2005, we redeemed $52 million principal amount of our 9 ½% Notes for a redemption price of 109.5% of the principal amount of the notes redeemed plus accrued interest, using restricted cash from a portion of the proceeds of the equity offering in November 2004.
                         
  Term  91/2%  53/4%  4%  21/4%    
  Loans/Other  Notes  Notes  Notes  Debenture  Total 
  (In millions) 
2006 $0.9  $  $  $  $  $0.9 
2007  1.0      19.8         20.8 
2008  1.0               1.0 
2009  1.0               1.0 
2010  50.7               50.7 
Thereafter     97.5      125.0   146.4   368.9 
                   
Total Debt $54.6  $97.5  $19.8  $125.0  $146.4  $443.3 
                   
     The NewSenior Credit Facility provides for an $80 milliona revolving credit facility (Revolver) maturing in December 2009, and a $100 million credit-linked facility maturing in December 2010. The2010; subject to early maturity in January 2007 if the 53/4% Notes remain outstanding or have not been cash collateralized by then. As of February 28, 2006, the credit-linked facility consistsconsisted of a $25$54.5 million term loan subfacility, and a $75$44.3 million letter of credit subfacility. Interest rates are based on LIBOR borrowings or Alternate Base Rate borrowings, as defined in the Credit Agreement. The interest rate on the Revolver is LIBOR plus 275225 basis points, or Alternate Base Rate plus 125 basis points, subject to adjustment based on our senior leverage ratio with a minimum of 225 basis points andto a maximum of LIBOR plus 300 basis points, or Alternate Base Rate plus 200 basis points. The interest rate on the term loan isfor fiscal 2006 has been amended to LIBOR plus 300325 basis points.points, or Alternate Base Rate plus 225 basis points, subject to a 50 basis point increase in the event that our senior secured debt ratings are lowered to certain levels. The fees on the letter of credit subfacility are 300for 2006 have also been amended to 325 basis points plus any shortfall from LIBOR earned on the credit-linked deposits. The Revolver commitment fee is .5% per annum on the unused balance of the Revolver. As of August 31, 2005,February 28, 2006, the borrowing limit under the Revolver was $80$80.0 million of which we had zero outstanding borrowings of $10 million.

36


borrowings. We also had $24$54.5 million outstanding on the term loan and $57$27.5 million outstanding letters of credit under the New Credit Facility. Cash proceeds from the term loan, netas of underwriting fees and expenses associated with the New Credit Facility, were $21 million and were used for general corporate purposes.February 28, 2006.
     The NewSenior Credit Facility is secured by substantially all of our assets, including the stock and assets of our material domestic subsidiaries whothat are guarantors of this facility. We are subject to certain limitations including the ability to: incur additional debt or sell assets, with restrictions on the use of proceeds; make certain investments and acquisitions; grant liens; and make restricted payments. We are also subject to financial covenants, effective for the period ended August 31, 2005,as amended which include an interest coverage ratio, fixed charge coverage ratio, a leverage ratio, and a senior leverage ratio. The fiscal 2005 financial covenants are as follows:
       
  Actual Ratios Required Covenants Required Covenants Dec. 1, 2005
Financial Covenant August 31, 2005February 28, 2006 Through November 30, 2005Dec. 1, 2005 Through Nov. 30, 2006
Interest coverage ratio 2.912.64 to 1.00 Not less than: 2.00 to 1.00 Not less than: 2.00 to 1.00
Fixed charge coverage ratio 1.152.03 to 1.00 Not less than: 1.10 to 1.00 Not less than: 1.15 to 1.00
Leverage ratio 6.386.24 to 1.00 Not greater than: 7.50 to 1.00Not greater than: 6.758.00 to 1.00
Senior leverage ratio 1.390.47 to 1.00 Not greater than: 2.50 to 1.00 Not greater than: 2.50 to 1.00
     Effective August 31, 2005,In January 2006, we entered into an Amendment to increase the maximum leverage covenant to 8.00 to 1.00 for fiscal 2006 and Waiverincrease the interest rate on the credit-linked facility as discussed above. We were in compliance with our covenants as of February 28, 2006.
     Pursuant to the Credit Agreement permitting us to provide seller financing in connection withindenture for our 91/2% Notes, if the net cash proceeds from sale of the Fine Chemicals business and waived compliance with the Fixed Charge Coverage Ratio covenant for the period calculated as of August 31, 2005 dueare not used to repay debt senior to the non-recurring investment for the Fine Chemicals business. We were91/2% Notes or reinvested in compliance with our financial covenants as of August 31, 2005.
     Various factors may affect our ability to comply with these financial covenants in the future, including the successful implementation of our operating plan, our ability to sell our Fine Chemicals business on a timely basis and the other risk factors described under “Forward-Looking Statements.” Our failureor before November 30, 2006, we will be required to comply with these covenants could result inmake an event of default that, if not cured or waived, could result in the acceleration of all or a substantial portion of our debt.
     In January 2004, we issued $125 millionoffer to purchase an aggregate principal amount of the 4%91/2% Notes generatingequal to the amount of such unused net sale proceeds at par plus accrued and unpaid interest in the first quarter of fiscal 2007.
     In June 2002, we filed a $300 million shelf registration statement with the Securities and Exchange Commission of which approximately $120$162 million with interest payments due in January and July, beginning July 2004. The net proceeds were used firstremains available for issuance. We may use the shelf to repay outstanding borrowings under the Restated Credit Facility, and to prepay the next 12 monthsissue debt securities, shares of scheduled principal amortization under Term Loan A. The remaining net proceeds were available to be used for general corporate purposes. Financing cash flows in 2004 also reflect activity related to foreign debt for the GDX Automotive business which was sold in August 2004.common stock, or preferred stock.

37


Outlook
     As disclosed in Notes 9(a) and 9(b)Note 10 in Notes to Unaudited Condensed Consolidated Financial Statements, we have exposure tofor certain legal matters. We believe that it is currently not possible to estimate the impact, if any, that the ultimate resolution of certain of these matters will have on our financial position or cash flows.
     We believe that our existing cash and cash equivalents and existing credit facilities forecasted operating cash flows, anticipated proceeds from the sale of our Fine Chemicals business, and our ability to access capital markets for debt or equity financing will provide sufficient funds to meet our operating plan for the next twelve months. The operating plan for this period provides for full operation of our businesses, including the Fine Chemicals business until it is sold, and interest and principal payments on our debt. We estimate an additional $7 million — $9 million will be paid by us during the remainder of fiscal 2006 related to the sale of the Fine Chemicals business. In addition, $13 million will be paid by us during the second quarter of fiscal 2006 for customer reimbursements of tax recoveries related to a unitary tax settlement (see Note 8 of the Unaudited Condensed Consolidated Financial Statements). Additionally, in the second quarter of fiscal 2006, we will issue $35 million — $42 million of additional letters of credit related to environmental obligations, of which $18 million — $25 million will be issued under our Revolver, reducing available borrowing capacity.
     We may also access capital markets to raise debt or equity financing to fund required debt payments and for acquisitions that make both strategic acquisitions.and economic sense. The timing, terms, size and pricing of any such financing will depend on investor interest and market conditions, and there can be no assurance that we will be able to obtain any such financing.
     Major factors that could adversely impact our forecasted operating cash and our financial condition are described below in the “Forward-Looking Statements” Section.“Risk Factors.” In addition, our liquidity and financial condition will continue to be affected by changes in prevailing interest rates on the portion of our debt that bears interest at variable interest rates.
Forward-Looking Statements
     Certain information contained in this report should be considered “forward-looking statements” as defined by Section 21E of the Private Securities ExchangeLitigation Reform Act of 1934.1995. All statements in this report other than historical information may be deemed forward-looking statements. These statements present (without limitation) the expectations, beliefs, plans and objectives of management and future financial performance and assumptions underlying, or judgments concerning, the matters discussed in the

37


statements. The words “believe,” “estimate,” “anticipate,” “project” and “expect,” and similar expressions, are intended to identify forward-looking statements. Forward-looking statements involve certain risks, estimates, assumptions and uncertainties, including with respect to future sales and activity levels, cash flows, contract performance, the outcome of litigation and contingencies, environmental remediation and anticipated costs of capital. A variety of factors could cause actual results or outcomes to differ materially from those expected and expressed in our forward-looking statements. Some important risk factors that could cause actual results or outcomes to differ from those expressed in the forward-looking statements are described in the section “Risk Factors” section in Item 1 in ourthe Annual Report of GenCorp to the U.S. Securities and Exchange Commission on Form 10-K for the year ended November 30, 2004. These factors2005 include, but are not limited to, the following:
the cancellation or material modification of one or more significant contracts or future reductions or changes in U.S. government spending;
product failures, schedule delays or other problems with existing or new products and systems or cost-overruns on our fixed-price contracts, including the Atlas V program contract that has not been profitable to date, and for which, unless we successfully renegotiate the contract, we may not recover our full cost of investment, resulting in additional write-downs;
significant competition and our inability to adapt to rapid technological changes;
failure to comply with regulations applicable to contracts with the U.S. government;
 environmental claims relatedcancellation or material modification of one or more significant contracts;
future reductions or changes in U.S. government spending;
failure to our currentcomply with regulations applicable to contracts with the U.S. government;
product failures, schedule delays or other problems with existing or new products and former businessessystems or cost-overruns on the Company’s fixed-price contracts;
significant competition and operations, including any costs we may incur if the offsetsCompany’s inability to adapt to rapid technological changes;
the judgment orderrelease or explosion of dangerous materials used in the amount of approximately $29 million entered November 21, 2002 against us inGenCorp Inc. v. Olin Corporation(U.S. District Court for the Northern District of Ohio, Eastern Division), to which we believe we are entitled, are not realized;Company’s businesses;
the possibility that the environmental and other government regulations that impact us will become more stringent or subject us to material liability in excess of our established reserves;
the release or explosion of dangerous materials used in our businesses;
disruptions in the supply of key raw materials and difficulties in the supplier qualification process, as well as increases in the prices of raw materials;

38


changes in economic and other conditions in the Sacramento County, California real estate market or changes in interest rates affecting real estate values in that market;
our limited experience in real estate development and the ability to execute our real estate business plan, including our ability to obtain all necessary zoning, land use and environmental approvals;
the cost of servicing our debt and compliance with financial and other covenants;
costs and time commitment related to acquisition activities;
our ability to monetize our real estate assets;
a strike or other work stoppage or our inability to renew collective bargaining agreements on favorable terms;
 
disruptions in the supply of key raw materials and difficulties in the supplier qualification process, as well as increases in the prices of raw materials;
reduction in airbag propellant volume;
a strike or other work stoppage or the Company’s inability to renew collective bargaining agreements on favorable terms;
 the loss of key employees and shortage of available skilled employees to achieve anticipated growth;
 
environmental claims related to the Company’s current and former businesses and operations;
the possibility that the environmental and other government regulations that impact the Company become more stringent or subject the Company to material liability in excess of its established reserves;
requirements to provide guarantees and/or letters of credit to financially assure the Company’s environmental obligations;
changes in economic and other conditions in the Sacramento County, California real estate market or changes in interest rates affecting real estate values in that market;
the Company’s limited experience in real estate activities and the ability to execute its real estate business plan, including the Company’s ability to obtain all necessary zoning, land use and environmental approvals;
the cost of servicing the Company’s debt and compliance with financial and other covenants;
effects of changes in discount rates and returns on plan assets of defined benefit pension plans could require the Company to increase its shareholders’ deficit;
 fluctuations in sales levels causing ourthe Company’s quarterly operating results to fluctuate;
 
additional costs related to the Company’s recent divestitures;
 a delay, or costs and time commitment related to acquisition activities;
inability to close on,effectively and efficiently implement the salenecessary initiatives to eliminate the material weakness we reported in our internal controls over financial reporting as of November 30, 2005; and · those risks detailed from time to time in the Fine Chemicals operations;Company’s reports filed with the SEC.
risks related to the Fine Chemicals business prior to its sale, including competition in the pharmaceutical fine chemicals market, the capital intensive nature of operations of the business, the lack of availability of raw materials and the highly energetic and potent nature of chemical compounds used in production; and
those risks detailed from time to time in our reports filed with the SEC.
     This list of factors that may affect future performance and the accuracy of forward-looking statements areis illustrative, but by no means exhaustive. These and other factors are described in more detail in our Annual Report on Form 10-K for the year ended November 30, 20042005 and our subsequent filings with the SEC.U.S. Securities and Exchange Commission. Additional risk factors may be described from time to time in our future filings with the SEC.U.S. Securities and Exchange Commission. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty. All such risk factors are difficult to predict, contain material uncertainties that may affect actual results and may be beyond our control.

38


Item 3. Quantitative and Qualitative Disclosures About Market Risk
     There have been no material changes to our disclosures related to certain market risks as reported under Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in ourthe Annual Report of GenCorp to the U.S. Securities and Exchange Commission on Form 10-K for the year ended November 30, 2004,2005, except as noted below.
Interest Rate Risk
     We are exposed to market risk principally due to changes in domestic interest rates. Debt with interest rate risk includes borrowings under our credit facilities. Other than pension assets, we do not have any significant exposure to interest rate risk related to our investments.
     We have used interest rate swaps and a combination of fixed and variable rate debt to reduce our exposure to interest rate risk. As of August 31, 2005,February 28, 2006, our debt totaled $424$443.3 million: $389$388.8 million, or 92%88% was at an average fixed rate of 4.81%; and $35$54.5 million or 8%12% was at a variable rate of 6.65%8.06%.
     The estimated fair value of our total debt was $490$508.7 million as of August 31, 2005February 28, 2006 compared to a carrying value of $424$443.3 million. The fair value of the convertible subordinated notes and the senior subordinated notes was determined based on quoted market prices as of August 31, 2005.February 28, 2006. The fair value of the remaining debt was determined to approximate carrying value as the interest rates are generally variable based on market interest rates and reflect current market rates available to us.

39


Long Term Debt
     The outstanding debt as of August 31, 2005, with maturities as follows:
                             
      Scheduled Payment Dates for the 
      years ended November 30, 
  Total  2005  2006  2007  2008  2009  Thereafter 
              (in millions)         
Total debt $424  $1  $1  $21  $1  $1  $399 
Item 4. Controls and Procedures
     Under the supervision and with the participation of our management, including the principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of August 31, 2005,February 28, 2006, the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded as of August 31, 2005February 28, 2006 that our disclosure controls and procedures were effective at the reasonable assurance level such that the information relating to us and our consolidated subsidiaries, required to be disclosed in our Securities and Exchange Commission (SEC) reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
     ThereDuring the first quarter of fiscal 2006, we have not been anyand will continue to implement changes into our processes to improve our internal controlcontrols over financial reporting that occurredreporting. The following steps have been and will be taken to remediate the conditions leading to the material weakness described within our Annual Report on Form 10-K for the fiscal year ended November 30, 2005:
Examination and modification, if necessary, of existing policies and procedures to identify areas where more explicit guidance is required to more clearly define roles and responsibilities for personnel with respect to the identification, escalation and review by appropriate finance and accounting personnel of complex, non-routine transactions in a timely manner.
Reassess existing processes to identify areas where related polices should be clarified with respect to the degree and extent of procedures and communication performed by key finance and accounting personnel in their review of accounting for complex, non-routine transactions.
     We hired a Vice President, Corporate Controller during the first quarter of fiscal quarter ended August 31, 2005 that have materially affected, or2006 and are reasonably likelyin the process of hiring additional finance and accounting personnel to materially affect,improve our internal controls. Finally, as part of our ongoing monitoring effort of the Company’s internal control over financial reporting.environment, we have and will report the progress and status of the above remediation actions to the Audit Committee throughout the year.

4039


PART II OTHER INFORMATION
Item 1. Legal Proceedings
     Except as disclosed in Note 9(a) and Note 9(b) in Part I,10, which areis incorporated herein by reference, there have been no significant developments in the pending legal proceedings as previously reported in ourthe Annual Report of GenCorp Inc. to the SEC on Form 10-K for the year ended November 30, 2004.2005. Reference is made to Part 1 Item 3, Legal Proceedings in our Annual Report on Form 10-K for the year ended November 30, 2004.2005.
     Vinyl Chloride Cases.The following table sets forth information related to our historical product liability costs associated with our vinyl chloride litigation cases.
                        
 Nine Months Year Year  Three Months Year Year 
 Ended Ended, Ended  Ended Ended, Ended 
 August 31, Nov. 30, Nov. 30,  Feb. 28, Nov. 30, Nov. 30, 
 2005 2004 2003  2006 2005 2004 
 (dollars in thousands)  (dollars in thousands) 
Claims filed 1 14 11   4 14 
Claims dismissed 9 8 4  1 9 8 
Claims settled  1 2  1 9 1 
Claims pending 16 24 19  8 10 24 
Aggregate settlement costs $ $425 $55  $50 $18 $425 
Average settlement costs $ $425 $27  $50 $2 $425 
     Legal and administrative fees for the vinyl chloride cases for the first nine monthsquarter of fiscal 20052006 were $0.3$0.1 million. Legal and administrative fees for the vinyl chloride cases for fiscal 20042005 and fiscal 20032004 were $0.4 million for each period.
     Asbestos Cases.The following table sets forth information related to our historical product liability costs associated with our asbestos litigation cases.
                        
 Nine Months Year Year  Three Months Year Year 
 Ended Ended, Ended  Ended Ended, Ended 
 August 31, Nov. 30, Nov. 30,  Feb. 28, Nov. 30, Nov. 30, 
 2005 2004 2003  2006 2005 2004 
 (dollars in thousands)  (dollars in thousands) 
Claims filed  89* 63 40  21  149* 63 
Claims dismissed 51 27 21  17 65 27 
Claims settled 1  8** 6  1 2  8**
Claims pending 107 70 42  155 152 70 
Aggregate settlement costs $50 $3,073** $226  $35 $50 $3,073**
Average settlement costs $50 $384** $38  $35 $25 $384**
 
* Includes 30 additional cases filed againsttendered to the Company by PCC Flow Technologies, Inc. and its affiliates (PCC) for which. PCC had originally tendered 57 cases to the Company, is requiredbut 27 of such cases were dismissed prior to defendthe Company’s and indemnify PCC, effectivePCC’s May 31, 2005.2005 settlement agreement.
 
** The number of claims settled and the aggregate settlement costs and average settlement costs for fiscal 2004 include theGoede et al. v. Chesterton Inc. et al.matter in which there was a judgment of approximately $5 million against Aerojet, which was reduced to approximately $2 million after setoff based on plaintiffs’ settlements with other defendants. The total amount paid, including interest accruing from the date of judgment, was $2 million.
     Legal and administrative fees for the asbestos cases for the first nine monthsquarter of fiscal 2005 were $0.32006 was $0.2 million. Legal and administrative fees for the asbestos cases for fiscal 20042005 and fiscal 20032004 were $0.5 million and $1.0 million, and $1.4 million, respectively.

40


Item 1A. Risk Factors.
     There have been no material changes from our risk factors as previously reported in our Annual Report to the SEC on Form 10-K for the year ended November 30, 2005.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
     None.

41


Item 3. Defaults upon Senior Securities
     None.
Item 4. Submission of Matters to a Vote of Security Holders
     None.
Item 5. Other Information
     None.
Item 6. Exhibits
A) Exhibits
   
No. Description
2.110.1*† Asset PurchaseConsulting Agreement dated as of July 12, 2005,February 28, 2006 by and among Aerojet Fine Chemicals LLC, Aerojet-General Corporationbetween Joseph Carleone and American Pacific Corporation was filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on July 18, 2005 (File No. 1-1520), and is incorporated herein by reference.GenCorp Inc.
   
31.1 Certification of Principal Executive Officer pursuant to Rule 13a – 14 (a) of the Securities Exchange Act of 1934, as amended.
   
31.2 Certification of Principal Financial Officer pursuant to Rule 13a – 14 (a) of the Securities Exchange Act of 1934, as amended.
   
32.1 Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a –14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
*Filed herewith. All other exhibits have been previously filed.
Management contract or compensatory plan or arrangement.

4241


     None.
Signatures
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
  GenCorp Inc.
     
Date: October 7, 2005April 10, 2006 By: /s/ Yasmin R. Seyal
     
    Yasmin R. Seyal
    Senior Vice President, Chief Financial Officer
    (Principal Financial Officer and Principal Accounting Officer)
     
Date: October 7, 2005April 10, 2006 By: /s/ Terry L. Hall
     
    Terry L. Hall
    Chairman of the Board, President and Chief
    Executive Officer (Principal Executive Officer)
Date: April 10, 2006By:/s/ R. Leon Blackburn
R. Leon Blackburn
Vice President and Controller
(Principal Accounting Officer)

4342


EXHIBIT INDEX
   
Exhibit No. Exhibit Description
2.1
10.1 Asset PurchaseConsulting Agreement dated as of July 12, 2005,February 28, 2006 by and among Aerojet Fine Chemicals LLC, Aerojet-General Corporationbetween Joseph Carleone and American Pacific Corporation was filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on July 18, 2005 (File No. 1-1520), and is incorporated herein by reference.GenCorp Inc.
   
31.1 Certification of Principal Executive Officer pursuant to Rule 13a – 14 (a) of the Securities Exchange Act of 1934, as amended.
   
31.2 Certification of Principal Financial Officer pursuant to Rule 13a – 14 (a) of the Securities Exchange Act of 1934, as amended
   
32.1 Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a – 14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

4443